daar ES - Search Results

Year	Number of Results
1989	1
1990	1
1991	5
1992	4
1993	2
1994	2
1995	2
1996	3
1997	4
1998	5
1999	5
2000	5
2001	7
2002	3
2003	5
2004	8
2005	12
2006	12
2007	8
2008	13
2009	6
2010	8
2011	11
2012	11
2013	17
2014	18
2015	10
2016	9
2017	9
2018	14
2019	8
2020	4
2021	8
2022	12
2023	29
2024	19
2025	15
2026	5

1

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.

Grinspoon SK, Fitch KV, Zanni MV, Fichtenbaum CJ, Umbleja T, Aberg JA, Overton ET, Malvestutto CD, Bloomfield GS, Currier JS, Martinez E, Roa JC, Diggs MR, Fulda ES, Paradis K, Wiviott SD, Foldyna B, Looby SE, Desvigne-Nickens P, Alston-Smith B, Leon-Cruz J, McCallum S, Hoffmann U, Lu MT, Ribaudo HJ, Douglas PS; REPRIEVE Investigators. Grinspoon SK, et al. N Engl J Med. 2023 Aug 24;389(8):687-699. doi: 10.1056/NEJMoa2304146. Epub 2023 Jul 23. N Engl J Med. 2023. Update in: N Engl J Med. 2024 May 2;390(17):1626-1628. doi: 10.1056/NEJMc2400870. PMID: 37486775 Free PMC article. Updated. Clinical Trial.

2

Two-drug regimens for HIV treatment.

Gibas KM, Kelly SG, Arribas JR, Cahn P, Orkin C, Daar ES, Sax PE, Taiwo BO. Gibas KM, et al. Among authors: daar es. Lancet HIV. 2022 Dec;9(12):e868-e883. doi: 10.1016/S2352-3018(22)00249-1. Epub 2022 Oct 26. Lancet HIV. 2022. PMID: 36309038 Free PMC article. Review.

3

Clinical targeting of HIV capsid protein with a long-acting small molecule.

Link JO, Rhee MS, Tse WC, Zheng J, Somoza JR, Rowe W, Begley R, Chiu A, Mulato A, Hansen D, Singer E, Tsai LK, Bam RA, Chou CH, Canales E, Brizgys G, Zhang JR, Li J, Graupe M, Morganelli P, Liu Q, Wu Q, Halcomb RL, Saito RD, Schroeder SD, Lazerwith SE, Bondy S, Jin D, Hung M, Novikov N, Liu X, Villaseñor AG, Cannizzaro CE, Hu EY, Anderson RL, Appleby TC, Lu B, Mwangi J, Liclican A, Niedziela-Majka A, Papalia GA, Wong MH, Leavitt SA, Xu Y, Koditek D, Stepan GJ, Yu H, Pagratis N, Clancy S, Ahmadyar S, Cai TZ, Sellers S, Wolckenhauer SA, Ling J, Callebaut C, Margot N, Ram RR, Liu YP, Hyland R, Sinclair GI, Ruane PJ, Crofoot GE, McDonald CK, Brainard DM, Lad L, Swaminathan S, Sundquist WI, Sakowicz R, Chester AE, Lee WE, Daar ES, Yant SR, Cihlar T. Link JO, et al. Among authors: daar es. Nature. 2020 Aug;584(7822):614-618. doi: 10.1038/s41586-020-2443-1. Epub 2020 Jul 1. Nature. 2020. PMID: 32612233 Free PMC article. Clinical Trial.

4

Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial.

Luetkemeyer AF, Chew KW, Lacey S, Hughes MD, Harrison LJ, Daar ES, Eron J, Fletcher CV, Greninger AL, Hessinger D, Li JZ, Mailhot D, Wohl D, Chayakulkeeree M, Mendoza JLA, Elistratova P, Makinde O, Morgan G, Portsmouth S, Uehara T, Smith D, Currier JS. Luetkemeyer AF, et al. Among authors: daar es. Clin Infect Dis. 2025 Jul 18;80(6):1235-1244. doi: 10.1093/cid/ciaf029. Clin Infect Dis. 2025. PMID: 39960062 Free PMC article. Clinical Trial.

5

Zinc and Coronavirus Disease 2019.

Swindells S, Eschenauer GA, Nason M, Daar ES. Swindells S, et al. Among authors: daar es. Clin Infect Dis. 2023 Aug 22;77(4):662. doi: 10.1093/cid/ciad229. Clin Infect Dis. 2023. PMID: 37072885 No abstract available.

6

Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial.

Lu MT, Ribaudo H, Foldyna B, Zanni MV, Mayrhofer T, Karady J, Taron J, Fitch KV, McCallum S, Burdo TH, Paradis K, Hedgire SS, Meyersohn NM, DeFilippi C, Malvestutto CD, Sturniolo A, Diggs M, Siminski S, Bloomfield GS, Alston-Smith B, Desvigne-Nickens P, Overton ET, Currier JS, Aberg JA, Fichtenbaum CJ, Hoffmann U, Douglas PS, Grinspoon SK; REPRIEVE Trial Writing Group. Lu MT, et al. JAMA Cardiol. 2024 Apr 1;9(4):323-334. doi: 10.1001/jamacardio.2023.5661. JAMA Cardiol. 2024. PMID: 38381407 Free PMC article.

7

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial.

Gallant J, Lazzarin A, Mills A, Orkin C, Podzamczer D, Tebas P, Girard PM, Brar I, Daar ES, Wohl D, Rockstroh J, Wei X, Custodio J, White K, Martin H, Cheng A, Quirk E. Gallant J, et al. Among authors: daar es. Lancet. 2017 Nov 4;390(10107):2063-2072. doi: 10.1016/S0140-6736(17)32299-7. Epub 2017 Aug 31. Lancet. 2017. PMID: 28867497 Clinical Trial.

8

HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe-HIVe Randomized Clinical Trial.

Marks KM, Kang M, Umbleja T, Cox A, Vigil KJ, Ta NT, Omoz-Oarhe A, Perazzo H, Kosgei J, Hatlen T, Price J, Katsidzira L, Supparatpinyo K, Knowles K, Alston-Smith BL, Rathod P, Sherman KE; ACTG 5379 (BEe-HIVe) Study Team. Marks KM, et al. JAMA. 2025 Jan 28;333(4):295-306. doi: 10.1001/jama.2024.24490. JAMA. 2025. PMID: 39616603 Free PMC article. Clinical Trial.

9

Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis.

Fichtenbaum CJ, Malvestutto CD, Watanabe MG, Davies Smith E, Ribaudo HJ, McCallum S, Fitch KV, Currier JS, Diggs MR, Chu SM, Aberg JA, Lu MT, Valencia J, Gómez-Ayerbe C, Brar I, Valdez Madruga J, Bloomfield GS, Douglas PS, Zanni MV, Grinspoon SK; REPRIEVE Investigators. Fichtenbaum CJ, et al. Lancet HIV. 2025 Jul;12(7):e496-e505. doi: 10.1016/S2352-3018(25)00043-8. Epub 2025 Jun 4. Lancet HIV. 2025. PMID: 40482662 Clinical Trial.

10

Variant-Specific Viral Kinetics in Acute COVID-19.

Ribeiro RM, Choudhary MC, Deo R, Giganti MJ, Moser C, Ritz J, Greninger AL, Regan J, Flynn JP, Wohl DA, Currier JS, Eron JJ, Hughes MD, Smith DM, Chew KW, Daar ES, Perelson AS, Li JZ; ACTIV-2/A5401 Study Team. Ribeiro RM, et al. Among authors: daar es. J Infect Dis. 2023 Aug 31;228(Suppl 2):S136-S143. doi: 10.1093/infdis/jiad314. J Infect Dis. 2023. PMID: 37650233 Free PMC article. Clinical Trial.

11

Immune Status and SARS-CoV-2 Viral Dynamics.

Li Y, Moser C, Aga E, Currier JS, Wohl DA, Daar ES, Ritz J, Greninger AL, Sieg S, Parikh UM, Coombs RW, Hughes MD, Eron JJ, Smith DM, Chew KW, Li JZ; ACTIV-2/A5401 Study Team. Li Y, et al. Among authors: daar es. J Infect Dis. 2023 Aug 31;228(Suppl 2):S111-S116. doi: 10.1093/infdis/jiad200. J Infect Dis. 2023. PMID: 37650232 Free PMC article. Clinical Trial.

12

Long COVID After Bamlanivimab Treatment.

Evering TH, Moser CB, Jilg N, Yeh E, Sanusi B, Wohl DA, Daar ES, Li JZ, Klekotka P, Javan AC, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW; ACTIV-2/A5401 Study Team. Evering TH, et al. Among authors: daar es. J Infect Dis. 2023 Aug 31;228(Suppl 2):S126-S135. doi: 10.1093/infdis/jiad286. J Infect Dis. 2023. PMID: 37650236 Free PMC article. Clinical Trial.

13

Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2.

Ramirez SI, Lopez PG, Faraji F, Parikh UM, Heaps A, Ritz J, Moser C, Eron JJ, Wohl D, Currier J, Daar ES, Greninger A, Klekotka P, Grifoni A, Weiskopf D, Sette A, Peters B, Hughes MD, Chew KW, Smith DM, Crotty S; Accelerating COVID-19 Therapeutic Interventions and Vaccines-2 (ACTIV-2)/A5401 Study Team. Ramirez SI, et al. Among authors: daar es. JCI Insight. 2024 Dec 20;9(24):e186078. doi: 10.1172/jci.insight.186078. JCI Insight. 2024. PMID: 39704169 Free PMC article.

14

Long-term metabolic changes with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-containing regimens for HIV.

Daar ES, Orkin C, Sax PE, Hagins D, Pozniak A, Workowski K, Brinson C, Tiraboschi JM, Liu H, Deaton C, Cohen C, Madera S, Hindman JT, Ramgopal M. Daar ES, et al. AIDS Res Ther. 2025 Apr 7;22(1):45. doi: 10.1186/s12981-025-00732-w. AIDS Res Ther. 2025. PMID: 40197415 Free PMC article. Clinical Trial.

15

Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohorts.

Ehrenberg PK, Geretz A, Volcic M, Izumi T, Yum LK, Waickman A, Shangguan S, Paquin-Proulx D, Creegan M, Bose M, Machmach K, McGraw A, Narahari A, Currier JR, Sacdalan C, Phanuphak N, Apps R, Corley M, Ndhlovu LC, Slike B, Krebs SJ, Anonworanich J, Tovanabutra S, Robb ML, Eller MA, Laird GM, Cyktor J, Daar ES, Crowell TA, Mellors JW, Vasan S, Michael NL, Kirchhoff F, Thomas R. Ehrenberg PK, et al. Among authors: daar es. Nat Commun. 2025 May 29;16(1):4975. doi: 10.1038/s41467-025-59833-9. Nat Commun. 2025. PMID: 40442100 Free PMC article.

16

Antiretroviral therapy: treatment-experienced individuals.

Calvo KR, Daar ES. Calvo KR, et al. Among authors: daar es. Infect Dis Clin North Am. 2014 Sep;28(3):439-56. doi: 10.1016/j.idc.2014.06.005. Epub 2014 Jul 8. Infect Dis Clin North Am. 2014. PMID: 25151565 Review.

17

Novel approaches to HIV therapy.

Daar ES. Daar ES. F1000Res. 2017 May 31;6:759. doi: 10.12688/f1000research.11164.1. eCollection 2017. F1000Res. 2017. PMID: 28649373 Free PMC article. Review.

18

ACTIV trials: cross-trial lessons learned for master protocol implementation.

Keshtkar-Jahromi M, Adam SJ, Brar I, Chung LK, Currier JS, Daar ES, Davey VJ, Denning ET, Gelijns AC, Higgs ES, Jagannathan P, Javan AC, Jensen TO, Jilg N, Kalomenidis I, Kim P, Nayak SU, Newell M, Taiwo BO, Yokum T, Delph Y. Keshtkar-Jahromi M, et al. Among authors: daar es. J Clin Transl Sci. 2024 Oct 15;8(1):e152. doi: 10.1017/cts.2024.507. eCollection 2024. J Clin Transl Sci. 2024. PMID: 39540114 Free PMC article. Review.

19

Single-cell analyses reveal that monocyte gene expression profiles influence HIV-1 reservoir size in acutely treated cohorts.

Ehrenberg PK, Geretz A, Volcic M, Izumi T, Yum L, Waickman A, Shangguan S, Paquin-Proulx D, Creegan M, Bose M, Machmach K, McGraw A, Narahari A, Currier JR, Sacdalan C, Phanuphak N, Apps R, Corley M, Ndhlovu LC, Slike B, Krebs SJ, Anonworanich J, Tovanabutra S, Robb ML, Eller MA, Laird GM, Cyktor J, Daar ES, Crowell TA, Mellors JW, Vasan S, Michael NL, Kirchhoff F, Thomas R. Ehrenberg PK, et al. Among authors: daar es. bioRxiv [Preprint]. 2024 Nov 15:2024.11.12.623270. doi: 10.1101/2024.11.12.623270. bioRxiv. 2024. Update in: Nat Commun. 2025 May 29;16(1):4975. doi: 10.1038/s41467-025-59833-9. PMID: 39605411 Free PMC article. Updated. Preprint.

20

Emerging resistance profiles of newly approved antiretroviral drugs.

Daar ES. Daar ES. Top HIV Med. 2008 Oct-Nov;16(4):110-6. Top HIV Med. 2008. PMID: 18838744 Review.

21

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab.

Nadig N, Bhimraj A, Cawcutt K, Chiotos K, Dzierba AL, Kim AY, Martin GS, Pearson JC, Shumaker AH, Baden LR, Bedimo R, Cheng VC, Chew KW, Daar ES, Glidden DV, Hardy EJ, Johnson S, Li JZ, MacBrayne C, Nakamura MM, Riley L, Shafer RW, Shoham S, Tebas P, Tien PC, Loveless J, Falck-Ytter Y, Morgan RL, Gandhi RT. Nadig N, et al. Among authors: daar es. Clin Infect Dis. 2026 Jan 16;81(Supplement_3):i13-i16. doi: 10.1093/cid/ciaf235. Clin Infect Dis. 2026. PMID: 40402009

22

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Abatacept.

Nadig N, Bhimraj A, Cawcutt K, Chiotos K, Dzierba AL, Kim AY, Martin GS, Pearson JC, Shumaker AH, Baden LR, Bedimo R, Cheng VC, Chew KW, Daar ES, Glidden DV, Hardy EJ, Johnson S, Li JZ, MacBrayne C, Nakamura MM, Riley L, Shafer RW, Shoham S, Tebas P, Tien PC, Loveless J, Falck-Ytter Y, Morgan RL, Gandhi RT. Nadig N, et al. Among authors: daar es. Clin Infect Dis. 2026 Jan 16;81(Supplement_3):i17-i21. doi: 10.1093/cid/ciaf354. Clin Infect Dis. 2026. PMID: 40923137

23

Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection.

Deo R, Choudhary MC, Moser C, Ritz J, Daar ES, Wohl DA, Greninger AL, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW, Li JZ; ACTIV-2/A5401 Study Team. Deo R, et al. Among authors: daar es. Ann Intern Med. 2023 Mar;176(3):348-354. doi: 10.7326/M22-2381. Epub 2023 Feb 21. Ann Intern Med. 2023. PMID: 36802755 Free PMC article.

24

ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic.

Keshtkar-Jahromi M, Anstrom KJ, Barkauskas C, Brown SM, Daar ES, Fischer W, Gibbs KW, Higgs ES, Hughes MD, Jagannathan P, LaVange L, Lindsell CJ, Nayak SU, Paredes R, Parmar M, Peltan ID, Proschan M, Shotwell MS, Vock DM, Yokum T, Adam SJ. Keshtkar-Jahromi M, et al. Among authors: daar es. J Clin Transl Sci. 2024 Oct 15;8(1):e151. doi: 10.1017/cts.2024.1. eCollection 2024. J Clin Transl Sci. 2024. PMID: 39478775 Free PMC article. Review.

25

Emtricitabine + tenofovir alafenamide for the treatment of HIV.

Corado KC, Daar ES. Corado KC, et al. Among authors: daar es. Expert Opin Pharmacother. 2017 Mar;18(4):427-432. doi: 10.1080/14656566.2017.1288720. Epub 2017 Feb 8. Expert Opin Pharmacother. 2017. PMID: 28151023 Review.

26

Next generation fixed dose combination pharmacotherapies for treating HIV.

Caplan MR, Daar ES, Corado KC. Caplan MR, et al. Among authors: daar es. Expert Opin Pharmacother. 2018 Apr;19(6):589-596. doi: 10.1080/14656566.2018.1450866. Epub 2018 Mar 20. Expert Opin Pharmacother. 2018. PMID: 29557204 Review.

27

Primary human immunodeficiency virus type 1 infection.

Soogoor M, Daar ES. Soogoor M, et al. Among authors: daar es. Curr HIV/AIDS Rep. 2005 Jun;2(2):55-60. doi: 10.1007/s11904-005-0019-1. Curr HIV/AIDS Rep. 2005. PMID: 16091249 Review.

28

A meta-analysis platform methodology for determining the comparative effectiveness of antihepatitis C virus regimens.

Broglio KR, Daar ES, Quintana M, Yuan Y, Kalsekar A, Spellberg B, Lewis RJ, Akker Dv, Detry MA, Le T, Berry SM. Broglio KR, et al. Among authors: daar es. J Comp Eff Res. 2015 Mar;4(2):101-14. doi: 10.2217/cer.14.69. J Comp Eff Res. 2015. PMID: 25825840 Free article. Review.

29

HepB-CpG Vaccine in People With HIV and Prior Nonresponse to HBV Vaccine: The BEe-HIVe Trial End-of-Study Results.

Marks KM, Kang M, Umbleja T, Cox A, Vigil KJ, Avihingsanon A, Sugandhavesa P, Katsidzira L, Kosgei J, Perazzo H, Price J, Caruso S, Knowles K, Alston-Smith BL, Rathod P, Sherman KE; ACTG 5379 (BEe-HIVe) Study Team. Marks KM, et al. JAMA. 2025 Sep 9;334(10):910-912. doi: 10.1001/jama.2025.9894. JAMA. 2025. PMID: 40601334 Free PMC article.

30

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.

Evering TH, Chew KW, Giganti MJ, Moser C, Pinilla M, Wohl DA, Currier JS, Eron JJ, Javan AC, Bender Ignacio R, Margolis D, Zhu Q, Ma J, Zhong L, Yan L, D'Andrea Nores U, Hoover K, Mocherla B, Choudhary MC, Deo R, Ritz J, Fischer WA, Fletcher CV, Li JZ, Hughes MD, Smith D, Daar ES; ACTIV-2/A5401 Study Team. Evering TH, et al. Among authors: daar es. Ann Intern Med. 2023 May;176(5):658-666. doi: 10.7326/M22-3428. Epub 2023 Apr 18. Ann Intern Med. 2023. PMID: 37068272 Free PMC article. Clinical Trial.

31

Two-drug regimens for treatment of naïve HIV-1 infection and as maintenance therapy.

Corado KC, Caplan MR, Daar ES. Corado KC, et al. Among authors: daar es. Drug Des Devel Ther. 2018 Nov 1;12:3731-3740. doi: 10.2147/DDDT.S140767. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30464404 Free PMC article. Review.

32

Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trial.

Liu H, Wang Y, Huang Y, Xiong D, Shen J, Siqueiros L, Bala V, Savage GM, Guerrero M, Corado K, Rosen MI, Fletcher CV, Daar ES. Liu H, et al. Among authors: daar es. EBioMedicine. 2022 Dec;86:104330. doi: 10.1016/j.ebiom.2022.104330. Epub 2022 Nov 10. EBioMedicine. 2022. PMID: 36372731 Free PMC article. Clinical Trial.

33

Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials.

Andrews LIB, Halloran ME, Neuzil KM, van der Laan L, Huang Y, Andriesen J, Patel M, Fisher LH, Janes H, Rouphael N, Walsh SR, Theodore DA, Tieu HV, Sobieszczyk M, El Sahly HM, Baden LR, Falsey AR, Campbell TB, Kelley CF, Healy CM, Immergluck L, Luft B, Hirsch I, de Bruyn G, Truyers C, Priddy F, Sumner KM, Flannery B, Follmann D, Gilbert PB; COVID-19 Prevention Network (CoVPN). Andrews LIB, et al. JAMA Netw Open. 2025 May 1;8(5):e2512763. doi: 10.1001/jamanetworkopen.2025.12763. JAMA Netw Open. 2025. PMID: 40434773 Free PMC article.

34

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.

Falsey AR, Sobieszczyk ME, Hirsch I, Sproule S, Robb ML, Corey L, Neuzil KM, Hahn W, Hunt J, Mulligan MJ, McEvoy C, DeJesus E, Hassman M, Little SJ, Pahud BA, Durbin A, Pickrell P, Daar ES, Bush L, Solis J, Carr QO, Oyedele T, Buchbinder S, Cowden J, Vargas SL, Guerreros Benavides A, Call R, Keefer MC, Kirkpatrick BD, Pullman J, Tong T, Brewinski Isaacs M, Benkeser D, Janes HE, Nason MC, Green JA, Kelly EJ, Maaske J, Mueller N, Shoemaker K, Takas T, Marshall RP, Pangalos MN, Villafana T, Gonzalez-Lopez A; AstraZeneca AZD1222 Clinical Study Group. Falsey AR, et al. Among authors: daar es. N Engl J Med. 2021 Dec 16;385(25):2348-2360. doi: 10.1056/NEJMoa2105290. Epub 2021 Sep 29. N Engl J Med. 2021. PMID: 34587382 Free PMC article. Clinical Trial.

35

Viral and Symptom Rebound in Untreated COVID-19 Infection.

Deo R, Choudhary MC, Moser C, Ritz J, Daar ES, Wohl DA, Greninger AL, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW, Li JZ; ACTIV-2/A5401 Study Team. Deo R, et al. Among authors: daar es. medRxiv [Preprint]. 2022 Aug 2:2022.08.01.22278278. doi: 10.1101/2022.08.01.22278278. medRxiv. 2022. PMID: 35982660 Free PMC article. Preprint.

36

Condomless Sex With Virologically Suppressed HIV-Infected Individuals: How Safe Is It?

Daar ES, Corado K. Daar ES, et al. JAMA. 2016 Jul 12;316(2):149-51. doi: 10.1001/jama.2016.5636. JAMA. 2016. PMID: 27404181 No abstract available.

37

Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection.

Boucau J, Chew KW, Choudhary MC, Deo R, Regan J, Flynn JP, Crain CR, Hughes MD, Ritz J, Moser C, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Coombs RW, Fischer WA 2nd, Daar ES, Wohl DA, Eron JJ, Currier JS, Smith DM; POSITIVES study team; Li JZ, Barczak AK; ACTIV-2/A5401 Study Team. Boucau J, et al. Among authors: daar es. Cell Rep Med. 2022 Jul 19;3(7):100678. doi: 10.1016/j.xcrm.2022.100678. Epub 2022 Jun 20. Cell Rep Med. 2022. PMID: 35793677 Free PMC article. Clinical Trial.

38

Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus.

Letendre SL, Chen H, McKhann A, Roa J, Vecchio A, Daar ES, Berzins B, Hunt PW, Marra CM, Campbell TB, Coombs RW, Ma Q, Swaminathan S, Macatangay BJC, Morse GD, Miller T, Rusin D, Greninger AL, Ha B, Alston-Smith B, Robertson K, Paul R, Spudich S; A5324 Study Team. Letendre SL, et al. Among authors: daar es. Clin Infect Dis. 2023 Sep 18;77(6):866-874. doi: 10.1093/cid/ciad265. Clin Infect Dis. 2023. PMID: 37183889 Free PMC article. Clinical Trial.

39

Dual protease inhibitor therapy in the management of the HIV-1.

Yu K, Daar ES. Yu K, et al. Among authors: daar es. Expert Opin Pharmacother. 2000 Dec;1(7):1331-42. doi: 10.1517/14656566.1.7.1331. Expert Opin Pharmacother. 2000. PMID: 11249468 Review.

40

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Infliximab.

Nadig N, Bhimraj A, Cawcutt K, Chiotos K, Dzierba AL, Kim AY, Martin GS, Pearson JC, Shumaker AH, Baden LR, Bedimo R, Cheng VC, Chew KW, Daar ES, Glidden DV, Hardy EJ, Johnson S, Li JZ, MacBrayne C, Nakamura MM, Riley L, Shafer RW, Shoham S, Tebas P, Tien PC, Loveless J, Falck-Ytter Y, Morgan RL, Gandhi RT. Nadig N, et al. Among authors: daar es. Clin Infect Dis. 2026 Jan 16;81(Supplement_3):i22-i26. doi: 10.1093/cid/ciaf355. Clin Infect Dis. 2026. PMID: 40831386

41

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness.

Bhimraj A, Falck-Ytter Y, Baden LR, Bedimo R, Cawcutt K, Cheng VC, Chew KW, Chiotos K, Daar ES, Dzierba AL, Glidden DV, Hardy EJ, Johnson S, Kim AY, Li JZ, MacBrayne C, Martin GS, Nadig N, Nakamura MM, Pearson JC, Riley L, Shafer RW, Shoham S, Shumaker AH, Tebas P, Tien PC, Loveless J, Morgan RL, Gandhi RT. Bhimraj A, et al. Among authors: daar es. Clin Infect Dis. 2026 Jan 16;81(Supplement_3):i1-i5. doi: 10.1093/cid/ciaf424. Clin Infect Dis. 2026. PMID: 40757658

42

Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols.

Lehmann DS, Ribaudo HJ, Daar ES, Gulick RM, Haubrich RH, Robbins GK, de Bakker PI, Haas DW, McLaren PJ. Lehmann DS, et al. Among authors: daar es. Pharmacogenet Genomics. 2015 Feb;25(2):51-9. doi: 10.1097/FPC.0000000000000106. Pharmacogenet Genomics. 2015. PMID: 25461247 Free PMC article.

43

Engaging communities in therapeutics clinical research during pandemics: Experiences and lessons from the ACTIV COVID-19 therapeutics research initiative.

Wohl DA, Adam SJ, Gibbs KW, Moskowitz AL, Ortel TL, Singh U, Jilg N, Evering TH, Fischer WA 2nd, Taiwo BO, Daar ES, Lindsell CJ, Naggie S, Rothman RL, Dunsmore SE, McAdams MP, Vail J, Jayaweera D. Wohl DA, et al. Among authors: daar es. J Clin Transl Sci. 2024 Oct 15;8(1):e156. doi: 10.1017/cts.2024.561. eCollection 2024. J Clin Transl Sci. 2024. PMID: 39540112 Free PMC article. Review.

44

Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy.

Choudhary MC, Chew KW, Deo R, Flynn JP, Regan J, Crain CR, Moser C, Hughes M, Ritz J, Ribeiro RM, Ke R, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Fletcher CV, Daar ES, Wohl DA, Eron JJ, Currier JS, Parikh UM, Sieg SF, Perelson AS, Coombs RW, Smith DM, Li JZ; ACTIV-2/A5401 Study Team. Choudhary MC, et al. Among authors: daar es. medRxiv [Preprint]. 2021 Sep 15:2021.09.03.21263105. doi: 10.1101/2021.09.03.21263105. medRxiv. 2021. PMID: 34545376 Free PMC article. Preprint.

45

Need for clear inclusion criteria in reviews of antiretroviral treatments - Authors' reply.

Gibas KM, Arribas JR, Cahn P, Daar ES, Taiwo BO. Gibas KM, et al. Among authors: daar es. Lancet HIV. 2023 Mar;10(3):e150-e151. doi: 10.1016/S2352-3018(23)00006-1. Epub 2023 Feb 8. Lancet HIV. 2023. PMID: 36773626 Free PMC article. No abstract available.

46

Potent antiretroviral therapy does more than just decrease viral load.

Daar ES. Daar ES. Clin Infect Dis. 1998 Dec;27(6):1514-6. doi: 10.1086/515020. Clin Infect Dis. 1998. PMID: 9868669 No abstract available.

47

Antiretroviral switch studies do matter.

Daar ES, Ruane P, DeJesus E, Stellbrink HJ, Molina JM. Daar ES, et al. Lancet HIV. 2018 Oct;5(10):e546. doi: 10.1016/S2352-3018(18)30259-5. Epub 2018 Oct 8. Lancet HIV. 2018. PMID: 30319119 No abstract available.

48

Advances in Treatment and Prevention of HIV.

Hatlen TJ, Bender Ignacio R, Daar ES. Hatlen TJ, et al. Among authors: daar es. JAMA. 2025 Feb 18;333(7):576-578. doi: 10.1001/jama.2024.24027. JAMA. 2025. PMID: 39616600 No abstract available.

49

Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses.

Ramirez SI, Grifoni A, Weiskopf D, Parikh UM, Heaps A, Faraji F, Sieg SF, Ritz J, Moser C, Eron JJ, Currier JS, Klekotka P, Sette A, Wohl DA, Daar ES, Hughes MD, Chew KW, Smith DM, Crotty S; Accelerating COVID-19 Therapeutic Interventions and Vaccines–2/A5401 (ACTIV-2/A5401) Study Team. Ramirez SI, et al. Among authors: daar es. JCI Insight. 2022 Dec 22;7(24):e163471. doi: 10.1172/jci.insight.163471. JCI Insight. 2022. PMID: 36378539 Free PMC article.

50

A community-partnered approach for diversity in COVID-19 vaccine clinical trials.

Castellon-Lopez Y, Landovitz R, Ntekume E, Porter C, Bross R, Hilder R, Lucas-Wright A, Daar ES, Chavez P, Blades C, Carson S, Morris D, Vassar S, Casillas A, Brown A. Castellon-Lopez Y, et al. Among authors: daar es. J Clin Transl Sci. 2022 Oct 6;7(1):e23. doi: 10.1017/cts.2022.471. eCollection 2023. J Clin Transl Sci. 2022. PMID: 36714798 Free PMC article.

51

Leveraging Multi-Ancestry Polygenic Risk Scores for Body Mass Index to Predict Antiretroviral Therapy-Induced Weight Gain.

Keat K, Hui D, Xiao B, Bradford Y, Cindi Z, Daar ES, Gulick R, Riddler SA, Sinxadi P, Haas DW, Ritchie MD. Keat K, et al. Among authors: daar es. Pac Symp Biocomput. 2023;28:233-244. Pac Symp Biocomput. 2023. PMID: 36540980 Free PMC article.

52

Alterations of gray and white matter volumes and cortical thickness in treated HIV-positive patients.

Joy A, Nagarajan R, Daar ES, Paul J, Saucedo A, Yadav SK, Guerrero M, Haroon E, Macey P, Thomas MA. Joy A, et al. Among authors: daar es. Magn Reson Imaging. 2023 Jan;95:27-38. doi: 10.1016/j.mri.2022.10.006. Epub 2022 Oct 17. Magn Reson Imaging. 2023. PMID: 36265696 Free article.

53

Potency and durability of antiretroviral therapy.

Daar ES. Daar ES. J Acquir Immune Defic Syndr. 2003 Oct 1;34 Suppl 2:S111-7. doi: 10.1097/00126334-200310012-00003. J Acquir Immune Defic Syndr. 2003. PMID: 14703939 Review. No abstract available.

54

Incorporating novel virologic tests into clinical practice.

Daar ES. Daar ES. Top HIV Med. 2007 Aug-Sep;15(4):126-9. Top HIV Med. 2007. PMID: 17720997 Review.

55

Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.

Chew KW, Moser C, Daar ES, Wohl DA, Li JZ, Coombs RW, Ritz J, Giganti M, Javan AC, Li Y, Choudhary MC, Deo R, Malvestutto C, Klekotka P, Price K, Nirula A, Fischer W, Bala V, Ribeiro RM, Perelson AS, Fletcher CV, Eron JJ, Currier JS; ACTIV-2/A5401 Study Team; Hughes MD, Smith DM. Chew KW, et al. Among authors: daar es. Nat Commun. 2022 Aug 22;13(1):4931. doi: 10.1038/s41467-022-32551-2. Nat Commun. 2022. PMID: 35995785 Free PMC article. Clinical Trial.

56

ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.

Currier JS, Moser C, Eron JJ, Chew KW, Smith DM, Javan AC, Wohl DA, Daar ES, Hughes MD; ACTIV-2/A5401 Study Team. Currier JS, et al. Among authors: daar es. J Infect Dis. 2023 Aug 31;228(Suppl 2):S77-S82. doi: 10.1093/infdis/jiad246. J Infect Dis. 2023. PMID: 37650231 Free PMC article. Clinical Trial.

57

SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19.

Jilg N, Giganti MJ, Chew KW, Shaw-Saliba K, Ritz J, Moser C, Evering TH, Daar ES, Eron JJ, Currier JS, Hughes MD, Lane HC, Dewar R, Smith DM, Li JZ. Jilg N, et al. Among authors: daar es. Clin Infect Dis. 2024 Oct 15;79(4):920-927. doi: 10.1093/cid/ciae324. Clin Infect Dis. 2024. PMID: 39018444 Free PMC article. Clinical Trial.

58

The acquired immunodeficiency syndrome (AIDS) dementia complex.

Ho DD, Bredesen DE, Vinters HV, Daar ES. Ho DD, et al. Among authors: daar es. Ann Intern Med. 1989 Sep 1;111(5):400-10. doi: 10.7326/0003-4819-111-5-400. Ann Intern Med. 1989. PMID: 2548429 Review.

59

Antiretroviral regimens for treatment-experienced patients with HIV-1 infection.

Lagnese M, Daar ES. Lagnese M, et al. Among authors: daar es. Expert Opin Pharmacother. 2008 Apr;9(5):687-700. doi: 10.1517/14656566.9.5.687. Expert Opin Pharmacother. 2008. PMID: 18345948 Review.

60

Newer antiretroviral agents and how to use them.

Kim HH, Daar ES. Kim HH, et al. Among authors: daar es. Curr HIV/AIDS Rep. 2009 May;6(2):55-62. doi: 10.1007/s11904-009-0009-9. Curr HIV/AIDS Rep. 2009. PMID: 19358775 Review.

61

Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials.

Moser CB, Chew KW, Giganti MJ, Li JZ, Aga E, Ritz J, Greninger AL, Javan AC, Bender Ignacio R, Daar ES, Wohl DA, Currier JS, Eron JJ, Smith DM, Hughes MD; ACTIV-2/A5401 Study Team. Moser CB, et al. Among authors: daar es. J Infect Dis. 2023 Aug 31;228(Suppl 2):S101-S110. doi: 10.1093/infdis/jiad285. J Infect Dis. 2023. PMID: 37650235 Free PMC article. Clinical Trial.

62

High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I.

Sax PE, Andreatta K, Molina JM, Daar ES, Hagins D, Acosta R, D'Antoni ML, Chang S, Martin R, Liu H, Blair C, McNicholl I, Gallant J, Collins SE, Martin H, White KL. Sax PE, et al. Among authors: daar es. AIDS. 2022 Sep 1;36(11):1511-1520. doi: 10.1097/QAD.0000000000003244. Epub 2022 Apr 23. AIDS. 2022. PMID: 35466963 Free PMC article.

63

Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial.

Choudhary MC, Chew KW, Deo R, Flynn JP, Regan J, Crain CR, Moser C, Hughes MD, Ritz J, Ribeiro RM, Ke R, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Fletcher CV, Daar ES, Wohl DA, Eron JJ, Currier JS, Parikh UM, Sieg SF, Perelson AS, Coombs RW, Smith DM, Li JZ; ACTIV-2/A5401 Study Team. Choudhary MC, et al. Among authors: daar es. Nat Microbiol. 2022 Nov;7(11):1906-1917. doi: 10.1038/s41564-022-01254-1. Epub 2022 Oct 26. Nat Microbiol. 2022. PMID: 36289399 Free PMC article. Clinical Trial.

64

Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials.

Borges ÁH, Lundh A, Tendal B, Bartlett JA, Clumeck N, Costagliola D, Daar ES, Echeverría P, Gisslén M, Huedo-Medina TB, Hughes MD, Huppler Hullsiek K, Khabo P, Komati S, Kumar P, Lockman S, MacArthur RD, Maggiolo F, Matteelli A, Miro JM, Oka S, Petoumenos K, Puls RL, Riddler SA, Sax PE, Sierra-Madero J, Torti C, Lundgren JD. Borges ÁH, et al. Among authors: daar es. Clin Infect Dis. 2016 Jul 15;63(2):268-80. doi: 10.1093/cid/ciw236. Epub 2016 Apr 18. Clin Infect Dis. 2016. PMID: 27090986 Free PMC article.

65

Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment.

Hua L, Andersen JW, Daar ES, Glesby MJ, Hollabaugh K, Tierney C. Hua L, et al. Among authors: daar es. AIDS. 2013 Nov 13;27(17):2725-34. doi: 10.1097/01.aids.0000432470.46379.dd. AIDS. 2013. PMID: 23921611 Free PMC article.

66

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody.

Phan T, Zitzmann C, Chew KW, Smith DM, Daar ES, Wohl DA, Eron JJ, Currier JS, Hughes MD, Choudhary MC, Deo R, Li JZ, Ribeiro RM, Ke R, Perelson AS; ACTIV-2/A5401 Study Team. Phan T, et al. Among authors: daar es. PLoS Pathog. 2024 Apr 18;20(4):e1011680. doi: 10.1371/journal.ppat.1011680. eCollection 2024 Apr. PLoS Pathog. 2024. PMID: 38635853 Free PMC article.

67

Progressive brain atrophy in chronically infected and treated HIV+ individuals.

Nir TM, Jahanshad N, Ching CRK, Cohen RA, Harezlak J, Schifitto G, Lam HY, Hua X, Zhong J, Zhu T, Taylor MJ, Campbell TB, Daar ES, Singer EJ, Alger JR, Thompson PM, Navia BA; HIV Neuroimaging Consortium. Nir TM, et al. Among authors: daar es. J Neurovirol. 2019 Jun;25(3):342-353. doi: 10.1007/s13365-019-00723-4. Epub 2019 Feb 14. J Neurovirol. 2019. PMID: 30767174 Free PMC article.

68

Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection.

Boucau J, Chew KW, Choudhary M, Deo R, Regan J, Flynn JP, Crain CR, Hughes MD, Ritz J, Moser C, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Coombs RW, Fischer WA 2nd, Daar ES, Wohl DA, Eron JJ, Currier JS, Smith DM, Li JZ, Barczak AK; ACTIV-2/A5401 Study Team. Boucau J, et al. Among authors: daar es. medRxiv [Preprint]. 2021 Dec 30:2021.12.25.21268211. doi: 10.1101/2021.12.25.21268211. medRxiv. 2021. Update in: Cell Rep Med. 2022 Jul 19;3(7):100678. doi: 10.1016/j.xcrm.2022.100678. PMID: 35018382 Free PMC article. Updated. Preprint.

69

Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019.

Li Y, Harrison LJ, Chew KW, Currier JS, Wohl DA, Daar ES, Evering TH, Wu R, Giganti M, Ritz J, Javan AC, Coombs RW, Moser C, Hughes MD, Eron JJ, Smith DM, Li JZ. Li Y, et al. Among authors: daar es. Clin Infect Dis. 2023 Feb 18;76(4):734-737. doi: 10.1093/cid/ciac818. Clin Infect Dis. 2023. PMID: 36210483 Free PMC article.

70

Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial.

Moser CB, Chew KW, Ritz J, Newell M, Javan AC, Eron JJ, Daar ES, Wohl DA, Currier JS, Smith DM, Hughes MD; ACTIV-2/A5401 Study Team. Moser CB, et al. Among authors: daar es. J Infect Dis. 2023 Aug 31;228(Suppl 2):S92-S100. doi: 10.1093/infdis/jiad209. J Infect Dis. 2023. PMID: 37650234 Free PMC article.

71

Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial.

Chew KW, Taiwo BO, Moser C, Daar ES, Wohl DA, Ritz J, Javan AC, Li JZ, Fischer W, Greninger AL, Bausch C, Luke T, Call R, Neytman G, Giganti MJ, Fletcher CV, Hughes MD, Eron JJ, Currier JS, Smith DM; ACTIV-2/A5401 Study Team. Chew KW, et al. Among authors: daar es. J Infect Dis. 2024 Nov 15;230(5):1177-1186. doi: 10.1093/infdis/jiae369. J Infect Dis. 2024. PMID: 39028902 Free PMC article. Clinical Trial.

72

Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens.

Leonard MA, Cindi Z, Bradford Y, Bourgi K, Koethe J, Turner M, Norwood J, Woodward B, Erdem H, Basham R, Baker P, Rebeiro PF, Sterling TR, Hulgan T, Daar ES, Gulick R, Riddler SA, Sinxadi P, Ritchie MD, Haas DW. Leonard MA, et al. Among authors: daar es. Clin Infect Dis. 2021 Oct 5;73(7):e2153-e2163. doi: 10.1093/cid/ciaa1219. Clin Infect Dis. 2021. PMID: 32829410 Free PMC article. Clinical Trial.

73

Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathies.

Harrison T, Miyahara S, Lee A, Evans S, Bastow B, Simpson D, Gilron I, Dworkin R, Daar ES, Wieclaw L, Clifford DB; ACTG A5252 Team. Harrison T, et al. Among authors: daar es. Pain Med. 2013 Jul;14(7):1039-47. doi: 10.1111/pme.12084. Epub 2013 Apr 8. Pain Med. 2013. PMID: 23565581 Free PMC article. Clinical Trial.

74

Virologic correlates of anti-CMV IgG levels in HIV-1-infected men.

Gianella S, Morris SR, Tatro E, Vargas MV, Haubrich RH, Daar ES, Dube MP, Richman DD, Little SJ, Smith DM. Gianella S, et al. Among authors: daar es. J Infect Dis. 2014 Feb 1;209(3):452-6. doi: 10.1093/infdis/jit434. Epub 2013 Aug 20. J Infect Dis. 2014. PMID: 23964106 Free PMC article.

75

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody.

Phan T, Zitzmann C, Chew KW, Smith DM, Daar ES, Wohl DA, Eron JJ, Currier JS, Hughes MD, Choudhary MC, Deo R, Li JZ, Ribeiro RM, Ke R, Perelson AS; ACTIV-2/A5401 Study Team. Phan T, et al. Among authors: daar es. bioRxiv [Preprint]. 2023 Sep 17:2023.09.14.557679. doi: 10.1101/2023.09.14.557679. bioRxiv. 2023. Update in: PLoS Pathog. 2024 Apr 18;20(4):e1011680. doi: 10.1371/journal.ppat.1011680. PMID: 37745410 Free PMC article. Updated. Preprint.

76

Measuring below the bar: what is it telling us?

Daar ES. Daar ES. AIDS. 2006 Nov 28;20(18):2385-7. doi: 10.1097/QAD.0b013e3280118a22. AIDS. 2006. PMID: 17117026 No abstract available.

77

Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19.

Taiwo BO, Chew KW, Moser C, Wohl DA, Daar ES, Li JZ, Greninger AL, Bausch C, Luke T, Hoover K, Neytman G, Giganti MJ, Olefsky M, Javan AC, Fletcher CV, Eron JJ, Currier JS, Hughes MD, Smith DM; ACTIV-2/A5401 Study Team. Taiwo BO, et al. Among authors: daar es. J Infect Dis. 2023 Jul 14;228(2):133-142. doi: 10.1093/infdis/jiad013. J Infect Dis. 2023. PMID: 36661240 Free PMC article. Clinical Trial.

78

HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection.

VanderVeen LA, Selzer L, Moldt B, Parvangada A, Li J, Ananworanich J, Crowell TA, Eron JJ, Daar ES, Haubrich R, Geleziunas R, Cyktor J, Mellors JW, Callebaut C. VanderVeen LA, et al. Among authors: daar es. AIDS. 2024 Mar 15;38(4):607-610. doi: 10.1097/QAD.0000000000003792. Epub 2023 Nov 16. AIDS. 2024. PMID: 38416554 Free PMC article.

79

Viral suppression and HIV transmission behaviors among hospitalized patients living with HIV.

Pan Y, Metsch LR, Gooden LK, Philbin MM, Daar ES, Douaihy A, Jacobs P, Del Rio C, Rodriguez AE, Feaster DJ. Pan Y, et al. Among authors: daar es. Int J STD AIDS. 2019 Aug;30(9):891-901. doi: 10.1177/0956462419846726. Epub 2019 Jun 3. Int J STD AIDS. 2019. PMID: 31159715 Free PMC article.

80

Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19.

Giganti MJ, Chew KW, Eron JJ, Li JZ, Pinilla M, Moser C, Javan AC, Fischer WA, Klekotka P, Margolis D, Wohl DA, Coombs RW, Daar ES, Smith DM, Currier JS, Hughes MD; ACTIV-2/A5401 Study Team. Giganti MJ, et al. Among authors: daar es. J Infect Dis. 2023 Aug 31;228(Suppl 2):S117-S125. doi: 10.1093/infdis/jiad287. J Infect Dis. 2023. PMID: 37650230 Free PMC article. Clinical Trial.

81

Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.

Chew KW, Moser C, Daar ES, Wohl DA, Li JZ, Coombs RW, Ritz J, Giganti M, Javan AC, Li Y, Choudhary MC, Deo R, Malvestutto C, Klekotka P, Price K, Nirula A, Fischer W, Bala V, Ribeiro RM, Perelson AS, Fletcher CV, Eron JJ, Currier JS; ACTIV-2/A5401 Study Team; Hughes MD, Smith DM. Chew KW, et al. Among authors: daar es. Nat Commun. 2023 Jan 19;14(1):333. doi: 10.1038/s41467-023-35835-3. Nat Commun. 2023. PMID: 36658128 Free PMC article. No abstract available.

82

One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial.

Jilg N, Chew KW, Giganti MJ, Daar ES, Wohl DA, Javan AC, Kantor A, Moser C, Coombs RW, Neytman G, Hoover K, Jana A, Hart PA, Greninger AL, Szurgot B, Eron JJ, Currier JS, Hughes MD, Smith DM, Li JZ; ACTIV-2/A5401 Study Team. Jilg N, et al. Among authors: daar es. Clin Infect Dis. 2023 Oct 5;77(7):941-949. doi: 10.1093/cid/ciad342. Clin Infect Dis. 2023. PMID: 37279602 Free PMC article. Clinical Trial.

83

Lymphocyte Count Derived Polygenic Score and Interindividual Variability in CD4 T-cell Recovery in Response to Antiretroviral Therapy.

Cardone KM, Dudek S, Keat K, Bradford Y, Cindi Z, Daar ES, Gulick R, Riddler SA, Lennox JL, Sinxadi P, Haas DW, Ritchie MD. Cardone KM, et al. Among authors: daar es. Pac Symp Biocomput. 2024;29:594-610. Pac Symp Biocomput. 2024. PMID: 38160309 Free PMC article.

84

SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human memory B cell epitope recognition suggesting antibody feedback.

Coelho CH, Bloom N, Ramirez SI, Parikh UM, Heaps A, Sieg SF, Greninger A, Ritz J, Moser C, Eron JJ, Currier JS, Klekotka P, Wohl DA, Daar ES, Li J, Hughes MD, Chew KW, Smith DM, Crotty S; Accelerating COVID-19 Therapeutic Interventions and Vaccines–2/A5401 (ACTIV-2/A5401) Study Team. Coelho CH, et al. Among authors: daar es. bioRxiv [Preprint]. 2023 Nov 22:2023.11.21.567575. doi: 10.1101/2023.11.21.567575. bioRxiv. 2023. Update in: J Infect Dis. 2024 Nov 15;230(5):1187-1196. doi: 10.1093/infdis/jiae371. PMID: 38045374 Free PMC article. Updated. Preprint.

85

SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback.

Bloom N, Ramirez SI, Cohn H, Parikh UM, Heaps A, Sieg SF, Greninger A, Ritz J, Moser C, Eron JJ, Bajic G, Currier JS, Klekotka P, Wohl DA, Daar ES, Li J, Hughes MD, Chew KW, Smith DM, Crotty S, Coelho CH; Accelerating COVID-19 Therapeutic Interventions and Vaccines–2/A5401 (ACTIV-2/A5401) Study Team. Bloom N, et al. Among authors: daar es. J Infect Dis. 2024 Nov 15;230(5):1187-1196. doi: 10.1093/infdis/jiae371. J Infect Dis. 2024. PMID: 39036987 Free PMC article. Clinical Trial.

86

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.

Evering TH, Moser C, Jilg N, Ritz J, Wohl DA, Li JZ, Margolis D, Javan AC, Eron JJ, Currier JS, Daar ES, Smith DM, Hughes MD, Chew KW; ACTIV-2/A5401 Study Team. Evering TH, et al. Among authors: daar es. EClinicalMedicine. 2024 Aug 16;75:102787. doi: 10.1016/j.eclinm.2024.102787. eCollection 2024 Sep. EClinicalMedicine. 2024. PMID: 39252866 Free PMC article.

87

Factors associated with D-dimer levels in HIV-infected individuals.

Borges AH, O'Connor JL, Phillips AN, Baker JV, Vjecha MJ, Losso MH, Klinker H, Lopardo G, Williams I, Lundgren JD; INSIGHT SMART Study Group; ESPRIT Study Group; SILCAAT Scientific Committee. Borges AH, et al. PLoS One. 2014 Mar 13;9(3):e90978. doi: 10.1371/journal.pone.0090978. eCollection 2014. PLoS One. 2014. PMID: 24626096 Free PMC article.

88

Medical management of AIDS patients. Bacterial and fungal infections.

Daar ES, Meyer RD. Daar ES, et al. Med Clin North Am. 1992 Jan;76(1):173-203. doi: 10.1016/s0025-7125(16)30376-5. Med Clin North Am. 1992. PMID: 1727536 Review.

89

Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials.

Bender Ignacio RA, Chew KW, Moser C, Currier JS, Eron JJ, Javan AC, Giganti MJ, Aga E, Gibbs M, Tchouakam Kouekam H, Johnsson E, Esser MT, Hoover K, Neytman G, Newell M, Daar ES, Fischer W, Fletcher CV, Li JZ, Greninger AL, Coombs RW, Hughes MD, Smith D, Wohl DA; Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)–2/A5401 Study Team. Bender Ignacio RA, et al. Among authors: daar es. JAMA Netw Open. 2023 Apr 3;6(4):e2310039. doi: 10.1001/jamanetworkopen.2023.10039. JAMA Netw Open. 2023. PMID: 37099295 Free PMC article. Clinical Trial.

90

Antiretroviral resistance in clinical practice.

Daar ES. Daar ES. J Int Assoc Physicians AIDS Care (Chic). 2003 Sep;2 Suppl 1:S4-18. J Int Assoc Physicians AIDS Care (Chic). 2003. PMID: 14569655 Review. No abstract available.

91

Impact of randomized antiretroviral therapy initiation on glucose metabolism.

Erlandson KM, Kitch D, Tierney C, Sax PE, Daar ES, Melbourne KM, Ha B, McComsey GA. Erlandson KM, et al. Among authors: daar es. AIDS. 2014 Jun 19;28(10):1451-61. doi: 10.1097/QAD.0000000000000266. AIDS. 2014. PMID: 24637543 Free PMC article. Clinical Trial.

92

Brief Report: Low-Dose Methotrexate Does Not Affect Measures of HIV-1 Persistence in Individuals With Chronically Treated HIV-1 Infection.

Cyktor JC, Yeh E, Ribaudo H, Hoeth D, Naqvi A, Bell T, Ridker PM, Fichtenbaum C, Daar ES, Havlir D, Tawakol A, Lederman MM, Stein JH, Deeks SG, Currier JS, Hsue PY, Mellors JW; A5314 Team. Cyktor JC, et al. Among authors: daar es. J Acquir Immune Defic Syndr. 2024 Aug 15;96(5):481-485. doi: 10.1097/QAI.0000000000003453. J Acquir Immune Defic Syndr. 2024. PMID: 39287554 Free PMC article. Clinical Trial.

93

Proprotein convertase subtisilin/kexin 9 levels decline with hepatitis C virus therapy in people with HIV/hepatitis C virus and correlate with inflammation.

Gandhi MM, Nguyen KL, Lake JE, Liao D, Khodabakhshian A, Guerrero M, Shufelt CL, Bairey Merz CN, Jordan WC, Daar ES, Bhattacharya D, Chew KW. Gandhi MM, et al. Among authors: daar es. AIDS. 2024 Mar 1;38(3):317-327. doi: 10.1097/QAD.0000000000003739. Epub 2023 Sep 29. AIDS. 2024. PMID: 37788081 Free PMC article.

94

Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial.

Crowell TA, Ritz J, Zheng L, Naqvi A, Cyktor JC, Puleo J, Clagett B, Lama JR, Kanyama C, Little SJ, Cohn SE, Riddler SA, Collier AC, Heath SL, Tantivitayakul P, Grinsztejn B, Arduino RC, Rooney JF, van Zyl GU, Coombs RW, Fox L, Ananworanich J, Eron JJ, Sieg SF, Mellors JW, Daar ES; AIDS Clinical Trials Group (ACTG) A5354/EARLIER Study Team. Crowell TA, et al. Among authors: daar es. AIDS. 2024 Jul 1;38(8):1141-1152. doi: 10.1097/QAD.0000000000003881. Epub 2024 Mar 13. AIDS. 2024. PMID: 38489580 Free PMC article. Clinical Trial.

95

Relative resistance of primary HIV-1 isolates to neutralization by soluble CD4.

Daar ES, Ho DD. Daar ES, et al. Am J Med. 1991 Apr 10;90(4A):22S-26S. doi: 10.1016/0002-9343(91)90407-o. Am J Med. 1991. PMID: 2018048 Review.

96

Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men¹.

Hoenigl M, Jain S, Moore D, Collins D, Sun X, Anderson PL, Corado K, Blumenthal JS, Daar ES, Milam J, Dubé MP, Morris S; California Collaborative Treatment Group 595 Team. Hoenigl M, et al. Among authors: daar es. Emerg Infect Dis. 2018 Dec;24(12):2292-302. doi: 10.3201/eid2412.180400. Emerg Infect Dis. 2018. PMID: 30457536 Free PMC article.

97

Burden of Hyperglycemia in Patients Receiving Corticosteroids for Severe COVID-19.

Fetters KB, Judge SP, Daar ES, Hatlen TJ. Fetters KB, et al. Among authors: daar es. Mayo Clin Proc Innov Qual Outcomes. 2022 Oct;6(5):484-487. doi: 10.1016/j.mayocpiqo.2022.07.004. Epub 2022 Aug 8. Mayo Clin Proc Innov Qual Outcomes. 2022. PMID: 35966031 Free PMC article.

98

Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events.

Haas DW, Bradford Y, Verma A, Verma SS, Eron JJ, Gulick RM, Riddler SA, Sax PE, Daar ES, Morse GD, Acosta EP, Ritchie MD. Haas DW, et al. Among authors: daar es. Pharmacogenet Genomics. 2018 Jul;28(7):179-187. doi: 10.1097/FPC.0000000000000341. Pharmacogenet Genomics. 2018. PMID: 29847509 Free PMC article. Clinical Trial.

99

Generalizing Evidence from Randomized Trials using Inverse Probability of Sampling Weights.

Buchanan AL, Hudgens MG, Cole SR, Mollan KR, Sax PE, Daar ES, Adimora AA, Eron JJ, Mugavero MJ. Buchanan AL, et al. Among authors: daar es. J R Stat Soc Ser A Stat Soc. 2018 Oct;181(4):1193-1209. doi: 10.1111/rssa.12357. Epub 2018 Feb 26. J R Stat Soc Ser A Stat Soc. 2018. PMID: 30555215 Free PMC article.

100

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial.

Jagannathan P, Chew KW, Giganti MJ, Hughes MD, Moser C, Main MJ, Monk PD, Javan AC, Li JZ, Fletcher CV, McCarthy C, Wohl DA, Daar ES, Eron JJ, Currier JS, Singh U, Smith DM, Fischer W; ACTIV-2/A5401 Study Team. Jagannathan P, et al. Among authors: daar es. EClinicalMedicine. 2023 Oct 6;65:102250. doi: 10.1016/j.eclinm.2023.102250. eCollection 2023 Nov. EClinicalMedicine. 2023. PMID: 37855026 Free PMC article.

101

Human immunodeficiency virus inhibits multilineage hematopoiesis in vivo.

Koka PS, Fraser JK, Bryson Y, Bristol GC, Aldrovandi GM, Daar ES, Zack JA. Koka PS, et al. Among authors: daar es. J Virol. 1998 Jun;72(6):5121-7. doi: 10.1128/JVI.72.6.5121-5127.1998. J Virol. 1998. PMID: 9573283 Free PMC article.

102

A Remotely-Delivered CBT and Contingency Management Therapy for Substance Using People with HIV.

Moore BA, Rosen MI, Wang Y, Shen J, Ablondi K, Sullivan A, Guerrero M, Siqueiros L, Daar ES, Liu H. Moore BA, et al. Among authors: daar es. AIDS Behav. 2015 Jun;19 Suppl 2(0 2):156-62. doi: 10.1007/s10461-014-0990-x. AIDS Behav. 2015. PMID: 25645326 Free PMC article.

103

Adherence to Antiretrovirals and HIV Viral Suppression Under COVID-19 Pandemic Interruption - Findings from a Randomized Clinical Trial Using Ingestible Sensors to Monitor Adherence.

Wang Y, Daar ES, Huang Y, Xiong D, Shen J, Zhou L, Siqueiros L, Guerrero M, Rosen MI, Liu H. Wang Y, et al. Among authors: daar es. AIDS Behav. 2023 Dec;27(12):4041-4051. doi: 10.1007/s10461-023-04118-9. Epub 2023 Jul 4. AIDS Behav. 2023. PMID: 37401993 Free PMC article. Clinical Trial.

104

Improving adherence to antiretroviral therapy.

Daar ES, Cohen C, Remien R, Sherer R, Smith K. Daar ES, et al. AIDS Read. 2003 Feb;13(2):81-2, 85-6, 88-90. AIDS Read. 2003. PMID: 12645492 Review.

105

Treatment of primary HIV infection.

Daar ES. Daar ES. MedGenMed. 2002 Nov 15;4(4):15. MedGenMed. 2002. PMID: 12817211 Free article. Review. No abstract available.

106

Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants.

Bednasz CJ, Venuto CS, Ma Q, Daar ES, Sax PE, Fischl MA, Collier AC, Smith KY, Tierney C, Yang Y, Wilding GE, Morse GD. Bednasz CJ, et al. Among authors: daar es. Ther Drug Monit. 2017 Dec;39(6):596-603. doi: 10.1097/FTD.0000000000000443. Ther Drug Monit. 2017. PMID: 29135907 Free PMC article.

107

Does the human immunodeficiency virus (HIV) RNA concentration in cerebrospinal fluid help clinicians diagnose or understand HIV-induced neurological disease?

Daar ES. Daar ES. Clin Infect Dis. 1998 May;26(5):1074-5. doi: 10.1086/520300. Clin Infect Dis. 1998. PMID: 9597228 No abstract available.

108

Platelet count kinetics following interruption of antiretroviral treatment.

Zetterberg E, Neuhaus J, Baker JV, Somboonwit C, Llibre JM, Palfreeman A, Chini M, Lundgren JD; INSIGHT SMART Study Group. Zetterberg E, et al. AIDS. 2013 Jan 2;27(1):59-68. doi: 10.1097/QAD.0b013e32835a104d. AIDS. 2013. PMID: 23018440 Free PMC article. Clinical Trial.

109

Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial.

Chew KW, Moser C, Yeh E, Wohl DA, Daar ES, Ritz J, Javan AC, Eron JJ, Currier JS, Smith DM, Hughes MD; ACTIV-2/A5401 Study Team. Chew KW, et al. Among authors: daar es. J Infect Dis. 2023 Aug 31;228(Suppl 2):S83-S91. doi: 10.1093/infdis/jiad300. J Infect Dis. 2023. PMID: 37650237 Free PMC article. Clinical Trial.

110

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.

Sax PE, Tierney C, Collier AC, Fischl MA, Mollan K, Peeples L, Godfrey C, Jahed NC, Myers L, Katzenstein D, Farajallah A, Rooney JF, Ha B, Woodward WC, Koletar SL, Johnson VA, Geiseler PJ, Daar ES; AIDS Clinical Trials Group Study A5202 Team. Sax PE, et al. Among authors: daar es. N Engl J Med. 2009 Dec 3;361(23):2230-40. doi: 10.1056/NEJMoa0906768. Epub 2009 Dec 1. N Engl J Med. 2009. PMID: 19952143 Free PMC article. Clinical Trial.

111

Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2.

Ramirez SI, Lopez PG, Faraji F, Parikh UM, Heaps A, Ritz J, Moser C, Eron JJ, Wohl DA, Currier JS, Daar ES, Greninger AL, Klekotka P, Grifoni A, Weiskopf D, Sette A, Peters B, Hughes MD, Chew KW, Smith DM, Crotty S; ACTIV-2/A5401 Study Team. Ramirez SI, et al. Among authors: daar es. bioRxiv [Preprint]. 2024 Aug 19:2023.10.25.564014. doi: 10.1101/2023.10.25.564014. bioRxiv. 2024. Update in: JCI Insight. 2024 Dec 20;9(24):e186078. doi: 10.1172/jci.insight.186078. PMID: 37961119 Free PMC article. Updated. Preprint.

112

Sexual Risk Compensation in a Pre-exposure Prophylaxis Demonstration Study Among Individuals at Risk of HIV.

Milam J, Jain S, Dubé MP, Daar ES, Sun X, Corado K, Ellorin E, Blumenthal J, Haubrich R, Moore DJ, Morris SR; CCTG Team. Milam J, et al. Among authors: daar es. J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):e9-e13. doi: 10.1097/QAI.0000000000001885. J Acquir Immune Defic Syndr. 2019. PMID: 30334877 Free PMC article.

113

Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19.

Moser C, Li JZ, Eron JJ, Aga E, Daar ES, Wohl DA, Coombs RW, Javan AC, Bender Ignacio RA, Jagannathan P, Ritz J, Sieg SF, Parikh UM, Hughes MD, Currier JS, Smith DM, Chew KW; ACTIV-2/A5401 Study Team. Moser C, et al. Among authors: daar es. Open Forum Infect Dis. 2022 Nov 11;9(11):ofac618. doi: 10.1093/ofid/ofac618. eCollection 2022 Nov. Open Forum Infect Dis. 2022. PMID: 36467293 Free PMC article.

114

Population Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Human Development From Infancy Through Adulthood.

Yang J, Nikanjam M, Best BM, Pinto J, Chadwick EG, Daar ES, Havens PL, Rakhmanina N, Capparelli EV. Yang J, et al. Among authors: daar es. J Clin Pharmacol. 2018 Dec;58(12):1604-1617. doi: 10.1002/jcph.1293. Epub 2018 Sep 25. J Clin Pharmacol. 2018. PMID: 30252146 Free PMC article.

115

Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adults.

Li B, Veturi Y, Verma A, Bradford Y, Daar ES, Gulick RM, Riddler SA, Robbins GK, Lennox JL, Haas DW, Ritchie MD. Li B, et al. Among authors: daar es. PLoS Genet. 2021 Apr 26;17(4):e1009464. doi: 10.1371/journal.pgen.1009464. eCollection 2021 Apr. PLoS Genet. 2021. PMID: 33901188 Free PMC article.

116

Antiretroviral-drug resistance among patients recently infected with HIV.

Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Mellors JW, Connick E, Conway B, Kilby M, Wang L, Whitcomb JM, Hellmann NS, Richman DD. Little SJ, et al. Among authors: daar es. N Engl J Med. 2002 Aug 8;347(6):385-94. doi: 10.1056/NEJMoa013552. N Engl J Med. 2002. PMID: 12167680 Free article.

117

Idiopathic CD4+ T-lymphocytopenia--immunodeficiency without evidence of HIV infection.

Ho DD, Cao Y, Zhu T, Farthing C, Wang N, Gu G, Schooley RT, Daar ES. Ho DD, et al. Among authors: daar es. N Engl J Med. 1993 Feb 11;328(6):380-5. doi: 10.1056/NEJM199302113280602. N Engl J Med. 1993. PMID: 8093634 Free article.

118

Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infection.

Vanpouille C, Introini A, Morris SR, Margolis L, Daar ES, Dube MP, Little SJ, Smith DM, Lisco A, Gianella S. Vanpouille C, et al. Among authors: daar es. AIDS. 2016 Jan;30(2):193-201. doi: 10.1097/QAD.0000000000000964. AIDS. 2016. PMID: 26558730 Free PMC article.

119

Trajectories and Predictors of Longitudinal Preexposure Prophylaxis Adherence Among Men Who Have Sex With Men.

Pasipanodya EC, Jain S, Sun X, Blumenthal J, Ellorin E, Corado K, Dube MP, Daar ES, Morris SR, Moore DJ; California Collaborative Treatment Group (CCTG) TAPIR Study Team. Pasipanodya EC, et al. Among authors: daar es. J Infect Dis. 2018 Oct 5;218(10):1551-1559. doi: 10.1093/infdis/jiy368. J Infect Dis. 2018. PMID: 30295803 Free PMC article. Clinical Trial.

120

Impaired Nef function is associated with early control of HIV-1 viremia.

Kuang XT, Li X, Anmole G, Mwimanzi P, Shahid A, Le AQ, Chong L, Qian H, Miura T, Markle T, Baraki B, Connick E, Daar ES, Jessen H, Kelleher AD, Little S, Markowitz M, Pereyra F, Rosenberg ES, Walker BD, Ueno T, Brumme ZL, Brockman MA. Kuang XT, et al. Among authors: daar es. J Virol. 2014 Sep 1;88(17):10200-13. doi: 10.1128/JVI.01334-14. Epub 2014 Jun 25. J Virol. 2014. PMID: 24965469 Free PMC article.

121

Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens.

Zheng Y, Hughes MD, Lockman S, Benson CA, Hosseinipour MC, Campbell TB, Gulick RM, Daar ES, Sax PE, Riddler SA, Haubrich R, Salata RA, Currier JS. Zheng Y, et al. Among authors: daar es. Clin Infect Dis. 2014 Sep 15;59(6):888-96. doi: 10.1093/cid/ciu367. Epub 2014 May 19. Clin Infect Dis. 2014. PMID: 24842909 Free PMC article.

122

Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202.

Grant PM, Tierney C, Budhathoki C, Daar ES, Sax PE, Collier AC, Fischl MA, Zolopa AR, Balamane M, Katzenstein D. Grant PM, et al. Among authors: daar es. HIV Clin Trials. 2013 Nov-Dec;14(6):284-91. doi: 10.1310/hct1406-284. HIV Clin Trials. 2013. PMID: 24334181 Free PMC article. Clinical Trial.

123

Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.

Strain MC, Little SJ, Daar ES, Havlir DV, Gunthard HF, Lam RY, Daly OA, Nguyen J, Ignacio CC, Spina CA, Richman DD, Wong JK. Strain MC, et al. Among authors: daar es. J Infect Dis. 2005 May 1;191(9):1410-8. doi: 10.1086/428777. Epub 2005 Mar 29. J Infect Dis. 2005. PMID: 15809898 Free article.

124

Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202.

Johnson DH, Venuto C, Ritchie MD, Morse GD, Daar ES, McLaren PJ, Haas DW. Johnson DH, et al. Among authors: daar es. Pharmacogenet Genomics. 2014 Apr;24(4):195-203. doi: 10.1097/FPC.0000000000000034. Pharmacogenet Genomics. 2014. PMID: 24557078 Free PMC article. Clinical Trial.

125

Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2.

Choudhary MC, Deo R, Evering TH, Chew KW, Giganti MJ, Moser C, Ritz J, Regan J, Flynn JP, Crain CR, Wohl DA, Currier JS, Eron JJ, Margolis D, Zhu Q, Zhon L, Ya L, Greninger AL, Hughes MD, Smith D, Daar ES, Li JZ. Choudhary MC, et al. Among authors: daar es. J Infect Dis. 2024 Aug 16;230(2):394-402. doi: 10.1093/infdis/jiae192. J Infect Dis. 2024. PMID: 38716969 Free PMC article. Clinical Trial.

126

Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial.

Corado KC, Chew KW, Giganti MJ, Mu Y, Fletcher CV, Currier JS, Daar ES, Wohl DA, Li JZ, Moser CB, Ritz J, Javan AC, Neytman G, Caskey M, Hughes MD, Smith DM, Eron JJ; ACTIV-2/A5401 Study Team. Corado KC, et al. Among authors: daar es. Pathog Immun. 2024 May 6;9(1):138-155. doi: 10.20411/pai.v9i1.660. eCollection 2024. Pathog Immun. 2024. PMID: 38746756 Free PMC article.

127

Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy.

Massanella M, Gianella S, Schrier R, Dan JM, Pérez-Santiago J, Oliveira MF, Richman DD, Little SJ, Benson CA, Daar ES, Dube MP, Haubrich RH, Smith DM, Morris SR. Massanella M, et al. Among authors: daar es. Sci Rep. 2015 Aug 24;5:13179. doi: 10.1038/srep13179. Sci Rep. 2015. PMID: 26299251 Free PMC article.

128

Brief Report: Effect of CMV and HIV Transcription on CD57 and PD-1 T-Cell Expression During Suppressive ART.

Dan JM, Massanella M, Smith DM, Spina CA, Schrier R, Daar ES, Dube MP, Morris SR, Gianella S. Dan JM, et al. Among authors: daar es. J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):133-7. doi: 10.1097/QAI.0000000000000936. J Acquir Immune Defic Syndr. 2016. PMID: 26818740 Free PMC article.

129

Short communication: HIV-1 gag genetic variation in a single acutely infected participant defined by high-resolution deep sequencing.

Al-Mawsawi LQ, Wu NC, De La Cruz J, Shi VC, Wu TT, Daar ES, Lewis MJ, Yang OO, Sun R. Al-Mawsawi LQ, et al. Among authors: daar es. AIDS Res Hum Retroviruses. 2014 Aug;30(8):806-11. doi: 10.1089/AID.2014.0097. Epub 2014 Jul 23. AIDS Res Hum Retroviruses. 2014. PMID: 24914638 Free PMC article.

130

HIV/AIDS. Assessment, testing, and natural history.

Katsufrakis PJ, Daar ES. Katsufrakis PJ, et al. Among authors: daar es. Prim Care. 1997 Sep;24(3):479-96. Prim Care. 1997. PMID: 9271688 Review.

131

Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation.

Crowell TA, Ritz J, Coombs RW, Zheng L, Eron JJ, Mellors JW, Dragavon J, van Zyl GU, Lama JR, Ruxrungtham K, Grinsztejn B, Arduino RC, Fox L, Ananworanich J, Daar ES; AIDS Clinical Trials Group A5354/EARLIER (Early ART to Limit Infection and Establishment of Reservoir) Study Team. Crowell TA, et al. Among authors: daar es. Clin Infect Dis. 2021 Aug 2;73(3):e643-e651. doi: 10.1093/cid/ciaa1893. Clin Infect Dis. 2021. PMID: 33382405 Free PMC article.

132

Initiation of Antiretroviral Therapy in the Hospital Is Associated With Linkage to Human Immunodeficiency Virus (HIV) Care for Persons Living With HIV and Substance Use Disorder.

Jacobs P, Feaster DJ, Pan Y, Gooden LK, Daar ES, Lucas GM, Jain MK, Marsh EL, Armstrong WS, Rodriguez A, Del Rio C, Metsch LR. Jacobs P, et al. Among authors: daar es. Clin Infect Dis. 2021 Oct 5;73(7):e1982-e1990. doi: 10.1093/cid/ciaa838. Clin Infect Dis. 2021. PMID: 32569355 Free PMC article. Clinical Trial.

133

Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants.

Mollan KR, Tierney C, Hellwege JN, Eron JJ, Hudgens MG, Gulick RM, Haubrich R, Sax PE, Campbell TB, Daar ES, Robertson KR, Ventura D, Ma Q, Edwards DRV, Haas DW; AIDS Clinical Trials Group. Mollan KR, et al. Among authors: daar es. J Infect Dis. 2017 Sep 1;216(5):554-564. doi: 10.1093/infdis/jix248. J Infect Dis. 2017. PMID: 28931220 Free PMC article. Clinical Trial.

134

Strategies for initiating combination antiretroviral therapy.

Tapper ML, Daar ES, Piliero PJ, Smith K, Steinhart C. Tapper ML, et al. Among authors: daar es. AIDS Patient Care STDS. 2005 Apr;19(4):224-38. doi: 10.1089/apc.2005.19.224. AIDS Patient Care STDS. 2005. PMID: 15857194 Review.

135

Real-Time and Wireless Assessment of Adherence to Antiretroviral Therapy With Co-Encapsulated Ingestion Sensor in HIV-Infected Patients: A Pilot Study.

Daar ES, Rosen MI, Wang Y, Siqueiros L, Shen J, Guerrero M, Xiong D, Dao J, Young T, Corado K, Fletcher CV, Liu H. Daar ES, et al. Clin Transl Sci. 2020 Jan;13(1):189-194. doi: 10.1111/cts.12701. Epub 2019 Oct 15. Clin Transl Sci. 2020. PMID: 31536156 Free PMC article. Clinical Trial.

136

Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.

Wanga V, Venuto C, Morse GD, Acosta EP, Daar ES, Haas DW, Li C, Shepherd BE. Wanga V, et al. Among authors: daar es. Pharmacogenet Genomics. 2015 Sep;25(9):450-61. doi: 10.1097/FPC.0000000000000156. Pharmacogenet Genomics. 2015. PMID: 26148204 Free PMC article. Clinical Trial.

137

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.

International HIV Controllers Study; Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, Plenge RM, Deeks SG, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore JM, Beattie N, Gupta S, Crenshaw A, Burtt NP, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E, Rosenberg R, Moss KL, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A, Lian J, Proudfoot J, Alvino DM, Vine S, Addo MM, Allen TM, Altfeld M, Henn MR, Le Gall S, Streeck H, Haas DW, Kuritzkes DR, Robbins GK, Shafer RW, Gulick RM, Shikuma CM, Haubrich R, Riddler S, Sax PE, Daar ES, Ribaudo HJ, Agan B, Agarwal S, Ahern RL, Allen BL, Altidor S, Altschuler EL, Ambardar S, Anastos K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J, Barton S, Basden P, Basgoz N, Bazner S, Bellos NC, Benson AM, Berger J, Bernard NF, Bernard AM, Birch C, Bodner SJ, Bolan RK, Boudreaux ET, Bradley M, Braun JF, Brndjar JE, Brown SJ, Brown K, Brown ST, Burack J, Bush LM, Cafaro V, Campbell O, Campbell J, Carlson RH, Carmichael… See abstract for full author list ➔ International HIV Controllers Study, et al. Among authors: daar es. Science. 2010 Dec 10;330(6010):1551-7. doi: 10.1126/science.1195271. Epub 2010 Nov 4. Science. 2010. PMID: 21051598 Free PMC article.

138

Platelet count is associated with plasma HIV type 1 RNA and disease progression.

Rieg G, Yeaman M, Lail AE, Donfield SM, Gomperts ED, Daar ES; Hemophilia Growth and Development Study (HGDS). Rieg G, et al. Among authors: daar es. AIDS Res Hum Retroviruses. 2007 Oct;23(10):1257-61. doi: 10.1089/aid.2006.0311. AIDS Res Hum Retroviruses. 2007. PMID: 17961113

139

Reduced antiretroviral drug susceptibility among patients with primary HIV infection.

Little SJ, Daar ES, D'Aquila RT, Keiser PH, Connick E, Whitcomb JM, Hellmann NS, Petropoulos CJ, Sutton L, Pitt JA, Rosenberg ES, Koup RA, Walker BD, Richman DD. Little SJ, et al. Among authors: daar es. JAMA. 1999 Sep 22-29;282(12):1142-9. doi: 10.1001/jama.282.12.1142. JAMA. 1999. PMID: 10501117

140

Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials.

Moser CB, Chew KW, Giganti MJ, Li JZ, Aga E, Ritz J, Greninger AL, Javan AC, Daar ES, Currier JS, Eron JJ, Smith DM, Hughes MD. Moser CB, et al. Among authors: daar es. medRxiv [Preprint]. 2023 Mar 17:2023.03.13.23287208. doi: 10.1101/2023.03.13.23287208. medRxiv. 2023. Update in: J Infect Dis. 2023 Aug 31;228(Suppl 2):S101-S110. doi: 10.1093/infdis/jiad285. PMID: 36993419 Free PMC article. Updated. Preprint.

141

Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202.

Ribaudo HJ, Daar ES, Tierney C, Morse GD, Mollan K, Sax PE, Fischl MA, Collier AC, Haas DW; DS Clinical Trials Group. Ribaudo HJ, et al. Among authors: daar es. J Infect Dis. 2013 Feb 1;207(3):420-5. doi: 10.1093/infdis/jis690. Epub 2012 Nov 12. J Infect Dis. 2013. PMID: 23148286 Free PMC article. Clinical Trial.

142

Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir.

McComsey GA, Kitch D, Daar ES, Tierney C, Jahed NC, Melbourne K, Ha B, Brown TT, Bloom A, Fedarko N, Sax PE. McComsey GA, et al. Among authors: daar es. AIDS. 2012 Jul 17;26(11):1371-85. doi: 10.1097/QAD.0b013e328354f4fb. AIDS. 2012. PMID: 22546988 Free PMC article. Clinical Trial.

143

Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202.

Bednasz CJ, Venuto CS, Ma Q, Daar ES, Sax PE, Fischl MA, Collier AC, Smith KY, Tierney C, Acosta EP, Mager DE, Morse GD; AIDS Clinical Trials Group Study A5202 Team. Bednasz CJ, et al. Among authors: daar es. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e01638-18. doi: 10.1128/AAC.01638-18. Print 2019 Apr. Antimicrob Agents Chemother. 2019. PMID: 30642925 Free PMC article. Clinical Trial.

144

2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis.

Bhimraj A, Falck-Ytter Y, Kim AY, Li JZ, Baden LR, Johnson S, Shafer RW, Shoham S, Tebas P, Bedimo R, Cheng VC, Chew KW, Chiotos K, Daar ES, Dzierba AL, Glidden DV, Hardy EJ, Martin GS, MacBrayne C, Nadig N, Nakamura MM, Shumaker AH, Tien P, Loveless J, Morgan RL, Gandhi RT. Bhimraj A, et al. Among authors: daar es. Clin Infect Dis. 2026 Jan 16;81(Supplement_3):i6-i12. doi: 10.1093/cid/ciae435. Clin Infect Dis. 2026. PMID: 39471458

145

Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy.

Anderson AM, Harezlak J, Bharti A, Mi D, Taylor MJ, Daar ES, Schifitto G, Zhong J, Alger JR, Brown MS, Singer EJ, Campbell TB, McMahon DD, Buchthal S, Cohen R, Yiannoutsos C, Letendre SL, Navia BA; HIV Neuroimaging Consortium. Anderson AM, et al. Among authors: daar es. J Acquir Immune Defic Syndr. 2015 May 1;69(1):29-35. doi: 10.1097/QAI.0000000000000532. J Acquir Immune Defic Syndr. 2015. PMID: 25622053 Free PMC article.

146

Primary HIV infection. Current trends in transmission, testing, and treatment.

Yu K, Daar ES. Yu K, et al. Among authors: daar es. Postgrad Med. 2000 Apr;107(4):114-6, 119-22. doi: 10.3810/pgm.2000.04.984. Postgrad Med. 2000. PMID: 10778415

147

Hepatitis C infection in dialysis patients: a link to poor clinical outcome?

Kalantar-Zadeh K, Daar ES, Eysselein VE, Miller LG. Kalantar-Zadeh K, et al. Among authors: daar es. Int Urol Nephrol. 2007;39(1):247-59. doi: 10.1007/s11255-006-9075-8. Epub 2006 Sep 29. Int Urol Nephrol. 2007. PMID: 17009087 Free article. Review.

148

Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection.

Meditz AL, MaWhinney S, Allshouse A, Feser W, Markowitz M, Little S, Hecht R, Daar ES, Collier AC, Margolick J, Kilby JM, Routy JP, Conway B, Kaldor J, Levy J, Schooley R, Cooper DA, Altfeld M, Richman D, Connick E. Meditz AL, et al. Among authors: daar es. J Infect Dis. 2011 Feb 15;203(4):442-51. doi: 10.1093/infdis/jiq085. Epub 2011 Jan 18. J Infect Dis. 2011. PMID: 21245157 Free PMC article.

149

Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine.

Smith KY, Tierney C, Mollan K, Venuto CS, Budhathoki C, Ma Q, Morse GD, Sax P, Katzenstein D, Godfrey C, Fischl M, Daar ES, Collier AC; AIDS Clinical Trials Group 5202 Study Team. Smith KY, et al. Among authors: daar es. Clin Infect Dis. 2014 Feb;58(4):555-63. doi: 10.1093/cid/cit747. Epub 2013 Nov 18. Clin Infect Dis. 2014. PMID: 24253247 Free PMC article. Clinical Trial.

150

Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network.

Daar ES, Little S, Pitt J, Santangelo J, Ho P, Harawa N, Kerndt P, Glorgi JV, Bai J, Gaut P, Richman DD, Mandel S, Nichols S; Los Angeles County Primary HIV Infection Recruitment Network. Daar ES, et al. Ann Intern Med. 2001 Jan 2;134(1):25-9. doi: 10.7326/0003-4819-134-1-200101020-00010. Ann Intern Med. 2001. PMID: 11187417

151

HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells.

Ikezoe T, Daar ES, Hisatake J, Taguchi H, Koeffler HP. Ikezoe T, et al. Among authors: daar es. Blood. 2000 Nov 15;96(10):3553-9. Blood. 2000. PMID: 11071654 Free article.

152

Relationships Between Adipose Mitochondrial Function, Serum Adiponectin, and Insulin Resistance in Persons With HIV After 96 Weeks of Antiretroviral Therapy.

Hulgan T, Ramsey BS, Koethe JR, Samuels DC, Gerschenson M, Libutti DE, Sax PE, Daar ES, McComsey GA, Brown TT. Hulgan T, et al. Among authors: daar es. J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):358-366. doi: 10.1097/QAI.0000000000001926. J Acquir Immune Defic Syndr. 2019. PMID: 30531304 Free PMC article.

153

Clinical and Sociobehavioral Prediction Model of 30-Day Hospital Readmissions Among People With HIV and Substance Use Disorder: Beyond Electronic Health Record Data.

Nijhawan AE, Metsch LR, Zhang S, Feaster DJ, Gooden L, Jain MK, Walker R, Huffaker S, Mugavero MJ, Jacobs P, Armstrong WS, Daar ES, Sullivan M, Del Rio C, Halm EA. Nijhawan AE, et al. Among authors: daar es. J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):330-341. doi: 10.1097/QAI.0000000000001925. J Acquir Immune Defic Syndr. 2019. PMID: 30763292 Free PMC article. Clinical Trial.

154

Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314.

Hsue PY, Ribaudo HJ, Deeks SG, Bell T, Ridker PM, Fichtenbaum C, Daar ES, Havlir D, Yeh E, Tawakol A, Lederman M, Currier JS, Stein JH. Hsue PY, et al. Among authors: daar es. Clin Infect Dis. 2019 May 17;68(11):1877-1886. doi: 10.1093/cid/ciy781. Clin Infect Dis. 2019. PMID: 30219823 Free PMC article. Clinical Trial.

155

Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density.

Erlandson KM, Kitch D, Tierney C, Sax PE, Daar ES, Tebas P, Melbourne K, Ha B, Jahed NC, McComsey GA. Erlandson KM, et al. Among authors: daar es. AIDS. 2013 Aug 24;27(13):2069-79. doi: 10.1097/QAD.0b013e328361d25d. AIDS. 2013. PMID: 24384588 Free PMC article. Clinical Trial.

156

Open-label, randomized, parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects.

Poland RE, Gertsik L, Favreau JT, Smith SI, Mirocha JM, Rao U, Daar ES. Poland RE, et al. Among authors: daar es. J Altern Complement Med. 2013 Apr;19(4):334-40. doi: 10.1089/acm.2012.0058. Epub 2012 Oct 25. J Altern Complement Med. 2013. PMID: 23098696 Free PMC article. Clinical Trial.

157

Transmission behaviors of recently HIV-infected men who have sex with men.

Gorbach PM, Drumright LN, Daar ES, Little SJ. Gorbach PM, et al. Among authors: daar es. J Acquir Immune Defic Syndr. 2006 May;42(1):80-5. doi: 10.1097/01.qai.0000196665.78497.f1. J Acquir Immune Defic Syndr. 2006. PMID: 16763494

158

Confronting the emergence of drug-resistant HIV type 1: impact of antiretroviral therapy on individual and population resistance.

Daar ES, Richman DD. Daar ES, et al. AIDS Res Hum Retroviruses. 2005 May;21(5):343-57. doi: 10.1089/aid.2005.21.343. AIDS Res Hum Retroviruses. 2005. PMID: 15929696 Review.

159

Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229.

McComsey GA, Walker UA, Budhathoki CB, Su Z, Currier JS, Kosmiski L, Naini LG, Charles S, Medvik K, Aberg JA; AIDS Clinical Trials Group A5229 Team. McComsey GA, et al. AIDS. 2010 Oct 23;24(16):2507-15. doi: 10.1097/QAD.0b013e32833ea9bc. AIDS. 2010. PMID: 20827170 Free PMC article. Clinical Trial.

160

Rapid generation of sequence variation during primary HIV-1 infection.

Pang S, Shlesinger Y, Daar ES, Moudgil T, Ho DD, Chen IS. Pang S, et al. Among authors: daar es. AIDS. 1992 May;6(5):453-60. doi: 10.1097/00002030-199205000-00003. AIDS. 1992. PMID: 1616650

161

Cystatin C-based renal function changes after antiretroviral initiation: a substudy of a randomized trial.

Gupta SK, Kitch D, Tierney C, Daar ES, Sax PE, Melbourne K, Ha B, McComsey GA; AIDS Clinical Trials Group Study A5224s Team. Gupta SK, et al. Among authors: daar es. Open Forum Infect Dis. 2014 Apr 16;1(1):ofu003. doi: 10.1093/ofid/ofu003. eCollection 2014 Mar. Open Forum Infect Dis. 2014. PMID: 25734077 Free PMC article.

162

Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study.

Bjerk SM, Baker JV, Emery S, Neuhaus J, Angus B, Gordin FM, Pett SL, Stephan C, Kunisaki KM; INSIGHT SMART Study Group. Bjerk SM, et al. PLoS One. 2013;8(2):e56249. doi: 10.1371/journal.pone.0056249. Epub 2013 Feb 15. PLoS One. 2013. PMID: 23457535 Free PMC article. Clinical Trial.

163

Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART.

Harezlak J, Cohen R, Gongvatana A, Taylor M, Buchthal S, Schifitto G, Zhong J, Daar ES, Alger JR, Brown M, Singer EJ, Campbell TB, McMahon D, So YT, Yiannoutsos CT, Navia BA; HIV Neuroimaging Consortium. Harezlak J, et al. Among authors: daar es. J Neurovirol. 2014 Jun;20(3):294-303. doi: 10.1007/s13365-014-0246-6. Epub 2014 Apr 3. J Neurovirol. 2014. PMID: 24696364 Free PMC article.

164

Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.

Nordell AD, McKenna M, Borges ÁH, Duprez D, Neuhaus J, Neaton JD; INSIGHT SMART, ESPRIT Study Groups; SILCAAT Scientific Committee. Nordell AD, et al. J Am Heart Assoc. 2014 May 28;3(3):e000844. doi: 10.1161/JAHA.114.000844. J Am Heart Assoc. 2014. PMID: 24870935 Free PMC article.

165

Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study.

Moore DJ, Jain S, Dubé MP, Daar ES, Sun X, Young J, Corado K, Ellorin E, Milam J, Collins D, Blumenthal J, Best BM, Anderson P, Haubrich R, Morris SR. Moore DJ, et al. Among authors: daar es. Clin Infect Dis. 2018 May 2;66(10):1566-1572. doi: 10.1093/cid/cix1055. Clin Infect Dis. 2018. PMID: 29228144 Free PMC article. Clinical Trial.

166

HIV viral kinetics and T cell dynamics in antiretroviral naïve persons starting an integrase strand transfer inhibitor and protease inhibitor regimen.

Karris MY, Jain S, Day TR, Pérez-Santiago J, Goicoechea M, Dubé MP, Sun X, Spina C, Daar ES, Haubrich RH, Morris S; California Collaborative Treatment Group (CCTG) 589 Study Team. Karris MY, et al. Among authors: daar es. HIV Clin Trials. 2017 Mar;18(2):67-74. doi: 10.1080/15284336.2017.1282578. Epub 2017 Jan 30. HIV Clin Trials. 2017. PMID: 28134057 Free PMC article. Clinical Trial.

167

Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.

Kearney M, Maldarelli F, Shao W, Margolick JB, Daar ES, Mellors JW, Rao V, Coffin JM, Palmer S. Kearney M, et al. Among authors: daar es. J Virol. 2009 Mar;83(6):2715-27. doi: 10.1128/JVI.01960-08. Epub 2008 Dec 30. J Virol. 2009. PMID: 19116249 Free PMC article.

168

Role of GB virus C in HIV-1-infected and hepatitis C virus-infected hemophiliac children and adolescents.

Tenckhoff S, Kaiser T, Bredeek F, Donfield S, Menius E, Lail A, Mössner J, Daar ES, Tillmann HL. Tenckhoff S, et al. Among authors: daar es. J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):243-8. doi: 10.1097/qai.0b013e31826218e1.. J Acquir Immune Defic Syndr. 2012. PMID: 23007118 Free PMC article.

169

Virology and immunology of acute HIV type 1 infection.

Daar ES. Daar ES. AIDS Res Hum Retroviruses. 1998 Oct;14 Suppl 3:S229-34. AIDS Res Hum Retroviruses. 1998. PMID: 9814948 Review.

170

Randomized Trial of a Health Coaching Intervention to Enhance Retention in Care: California Collaborative Treatment Group 594.

Corado K, Jain S, Morris S, Dube MP, Daar ES, He F, Aldous JL, Sitapati A, Haubrich R, Milam J, Karris MY. Corado K, et al. Among authors: daar es. AIDS Behav. 2018 Aug;22(8):2698-2710. doi: 10.1007/s10461-018-2132-3. AIDS Behav. 2018. PMID: 29725790 Free PMC article. Clinical Trial.

171

Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248.

Andrade A, Rosenkranz SL, Cillo AR, Lu D, Daar ES, Jacobson JM, Lederman M, Acosta EP, Campbell T, Feinberg J, Flexner C, Mellors JW, Kuritzkes DR; AIDS Clinical Trials Group A5248 Team. Andrade A, et al. Among authors: daar es. J Infect Dis. 2013 Sep;208(6):884-91. doi: 10.1093/infdis/jit272. Epub 2013 Jun 24. J Infect Dis. 2013. PMID: 23801609 Free PMC article. Clinical Trial.

172

Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.

Longenecker CT, Kitch D, Sax PE, Daar ES, Tierney C, Gupta SK, McComsey GA; AIDS Clinical Trials Group Study A5224s Team. Longenecker CT, et al. Among authors: daar es. J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):168-77. doi: 10.1097/QAI.0000000000000557. J Acquir Immune Defic Syndr. 2015. PMID: 26009829 Free PMC article. Clinical Trial.

173

Perceptions of People Living with HIV and HIV Healthcare Providers on Real-Time Measuring and Monitoring of Antiretroviral Adherence Using Ingestible Sensors: A Qualitative Study.

Kamal S, Rosen MI, Lazar C, Siqueiros L, Wang Y, Daar ES, Liu H. Kamal S, et al. Among authors: daar es. AIDS Res Treat. 2020 May 27;2020:1098109. doi: 10.1155/2020/1098109. eCollection 2020. AIDS Res Treat. 2020. PMID: 32566285 Free PMC article.

174

Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicentre, phase 3, non-inferiority trial.

Daar ES, DeJesus E, Ruane P, Crofoot G, Oguchi G, Creticos C, Rockstroh JK, Molina JM, Koenig E, Liu YP, Custodio J, Andreatta K, Graham H, Cheng A, Martin H, Quirk E. Daar ES, et al. Lancet HIV. 2018 Jul;5(7):e347-e356. doi: 10.1016/S2352-3018(18)30091-2. Epub 2018 Jun 18. Lancet HIV. 2018. PMID: 29925490 Clinical Trial.

175

Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200.

Para MF, Schouten J, Rosenkranz SL, Yu S, Weiner D, Tebas P, White CJ, Reeds D, Lertora J, Patterson KB, Daar ES, Cavert W, Brizz B; ACTG A5200 Team of the ACTG. Para MF, et al. Among authors: daar es. J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):491-5. doi: 10.1097/QAI.0b013e3181d142cb. J Acquir Immune Defic Syndr. 2010. PMID: 20130470 Free PMC article. Clinical Trial.

176

Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578).

Wagner GJ, Kanouse DE, Golinelli D, Miller LG, Daar ES, Witt MD, Diamond C, Tilles JG, Kemper CA, Larsen R, Goicoechea M, Haubrich RH. Wagner GJ, et al. Among authors: daar es. AIDS. 2006 Jun 12;20(9):1295-302. doi: 10.1097/01.aids.0000232238.28415.d2. AIDS. 2006. PMID: 16816559 Clinical Trial.

177

Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202.

Venuto CS, Mollan K, Ma Q, Daar ES, Sax PE, Fischl M, Collier AC, Smith KY, Tierney C, Morse GD. Venuto CS, et al. Among authors: daar es. J Antimicrob Chemother. 2014 Dec;69(12):3300-10. doi: 10.1093/jac/dku303. Epub 2014 Aug 25. J Antimicrob Chemother. 2014. PMID: 25159623 Free PMC article. Clinical Trial.

178

What's next? Treatment options when the first antiretroviral regimen fails virologically or is not tolerated, Part 1.

Ruane PJ, Daar ES. Ruane PJ, et al. Among authors: daar es. AIDS Read. 2004 Aug;14(8):421-6, 431-2, 434. AIDS Read. 2004. PMID: 15338522 Review.

179

Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy.

Deo R, Choudhary MC, Glover OT, Ignacio RB, Boucau J, Chew KW, Moser C, Currier JS, Eron JJ, Javan AC, Giganti MJ, Aga E, Gibbs M, Cohen T, Streicher K, Soboleva K, Fletcher CV, Daar ES, Greninger AL, Coombs RW, Fischer W, Hughes MD, Smith D, Wohl DA, Barczak AK, Li JZ. Deo R, et al. Among authors: daar es. Open Forum Infect Dis. 2025 Sep 8;12(9):ofaf542. doi: 10.1093/ofid/ofaf542. eCollection 2025 Sep. Open Forum Infect Dis. 2025. PMID: 40980587 Free PMC article.

180

A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor.

Doranz BJ, Grovit-Ferbas K, Sharron MP, Mao SH, Goetz MB, Daar ES, Doms RW, O'Brien WA. Doranz BJ, et al. Among authors: daar es. J Exp Med. 1997 Oct 20;186(8):1395-400. doi: 10.1084/jem.186.8.1395. J Exp Med. 1997. PMID: 9334380 Free PMC article.

181

Genital Epstein Barr Virus is associated with higher prevalence and persistence of anal human papillomavirus in HIV-infected men on antiretroviral therapy.

Gianella S, Ginocchio CC, Daar ES, Dube MP, Morris SR. Gianella S, et al. Among authors: daar es. BMC Infect Dis. 2016 Jan 25;16:24. doi: 10.1186/s12879-016-1356-y. BMC Infect Dis. 2016. PMID: 26809559 Free PMC article.

182

Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment.

Gianella S, Massanella M, Richman DD, Little SJ, Spina CA, Vargas MV, Lada SM, Daar ES, Dube MP, Haubrich RH, Morris SR, Smith DM; California Collaborative Treatment Group 592 Team. Gianella S, et al. Among authors: daar es. J Virol. 2014 Jul;88(14):7818-27. doi: 10.1128/JVI.00831-14. Epub 2014 Apr 30. J Virol. 2014. PMID: 24789781 Free PMC article.

183

Associations of inflammatory markers with AIDS and non-AIDS clinical events after initiation of antiretroviral therapy: AIDS clinical trials group A5224s, a substudy of ACTG A5202.

McComsey GA, Kitch D, Sax PE, Tierney C, Jahed NC, Melbourne K, Ha B, Brown TT, Bloom A, Fedarko N, Daar ES. McComsey GA, et al. Among authors: daar es. J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):167-74. doi: 10.1097/01.qai.0000437171.00504.41. J Acquir Immune Defic Syndr. 2014. PMID: 24121755 Free PMC article. Clinical Trial.

184

Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine.

Wyatt CM, Kitch D, Gupta SK, Tierney C, Daar ES, Sax PE, Ha B, Melbourne K, McComsey GA; AIDS Clinical Trials Group Study A5224s Team. Wyatt CM, et al. Among authors: daar es. J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):36-44. doi: 10.1097/QAI.0000000000000245. J Acquir Immune Defic Syndr. 2014. PMID: 25117929 Free PMC article. Clinical Trial.

185

Ineffectual targeting of HIV-1 Nef by cytotoxic T lymphocytes in acute infection results in no functional impairment or viremia reduction.

De La Cruz J, Vollbrecht T, Frohnen P, Ng HL, Daar ES, Yang OO, Lewis MJ. De La Cruz J, et al. Among authors: daar es. J Virol. 2014 Jul;88(14):7881-92. doi: 10.1128/JVI.00482-14. Epub 2014 Apr 30. J Virol. 2014. PMID: 24789790 Free PMC article.

186

Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.

Mollan KR, Smurzynski M, Eron JJ, Daar ES, Campbell TB, Sax PE, Gulick RM, Na L, O'Keefe L, Robertson KR, Tierney C. Mollan KR, et al. Among authors: daar es. Ann Intern Med. 2014 Jul 1;161(1):1-10. doi: 10.7326/M14-0293. Ann Intern Med. 2014. PMID: 24979445 Free PMC article.

187

Abacavir and tenofovir disoproxil fumarate co-administration results in a nonadditive antiviral effect in HIV-1-infected patients.

Goicoechea M, Jain S, Bi L, Kemper C, Daar ES, Diamond C, Ha B, Flaherty J, Sun S, Richman D, Louie S, Haubrich R; California Collaborative Treatment Group. Goicoechea M, et al. Among authors: daar es. AIDS. 2010 Mar 13;24(5):707-16. doi: 10.1097/QAD.0b013e32833676eb. AIDS. 2010. PMID: 20087154 Clinical Trial.

188

Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort.

Robertson KR, Su Z, Margolis DM, Krambrink A, Havlir DV, Evans S, Skiest DJ; A5170 Study Team. Robertson KR, et al. Neurology. 2010 Apr 20;74(16):1260-6. doi: 10.1212/WNL.0b013e3181d9ed09. Epub 2010 Mar 17. Neurology. 2010. PMID: 20237308 Free PMC article. Clinical Trial.

189

Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies.

Bender Ignacio RA, Chew KW, Moser C, Currier JS, Eron JJ, Javan AC, Giganti MJ, Ritz J, Gibbs M, Kouekam HT, Esser MT, Daar ES, Choudhary M, Deo R, Fletcher CV, Li JZ, Hughes MD, Smith D, Wohl DA; ACTIV-2/A5401 Study Team. Bender Ignacio RA, et al. Among authors: daar es. iScience. 2025 Feb 4;28(3):111938. doi: 10.1016/j.isci.2025.111938. eCollection 2025 Mar 21. iScience. 2025. PMID: 40124489 Free PMC article.

190

Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial.

Gallant JE, Daar ES, Raffi F, Brinson C, Ruane P, DeJesus E, Johnson M, Clumeck N, Osiyemi O, Ward D, Morales-Ramirez J, Yan M, Abram ME, Plummer A, Cheng AK, Rhee MS. Gallant JE, et al. Among authors: daar es. Lancet HIV. 2016 Apr;3(4):e158-65. doi: 10.1016/S2352-3018(16)00024-2. Epub 2016 Mar 14. Lancet HIV. 2016. PMID: 27036991 Clinical Trial.

191

What's next? Treatment options when the first antiretroviral regimen fails virologically or is not tolerated, Part 2.

Ruane PJ, Daar ES. Ruane PJ, et al. Among authors: daar es. AIDS Read. 2004 Sep;14(9):487-98. AIDS Read. 2004. PMID: 15457602 Review.

192

Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue.

Karris MY, Jain S, Bowman VQ, Rieg G, Goicoechea M, Dube MP, Kerkar S, Kemper C, Diamond C, Sun X, Daar ES, Haubrich RH, Morris S; California Collaborative Treatment Group (CCTG) 589 Study Team. Karris MY, et al. Among authors: daar es. J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):e48-50. doi: 10.1097/QAI.0000000000000990. J Acquir Immune Defic Syndr. 2016. PMID: 26977746 Free PMC article. Clinical Trial. No abstract available.

193

Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites.

Brown AJ, Precious HM, Whitcomb JM, Wong JK, Quigg M, Huang W, Daar ES, D'Aquila RT, Keiser PH, Connick E, Hellmann NS, Petropoulos CJ, Richman DD, Little SJ. Brown AJ, et al. Among authors: daar es. J Virol. 2000 Nov;74(22):10269-73. doi: 10.1128/jvi.74.22.10269-10273.2000. J Virol. 2000. PMID: 11044070 Free PMC article.

194

Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants.

Holzinger ER, Grady B, Ritchie MD, Ribaudo HJ, Acosta EP, Morse GD, Gulick RM, Robbins GK, Clifford DB, Daar ES, McLaren P, Haas DW. Holzinger ER, et al. Among authors: daar es. Pharmacogenet Genomics. 2012 Dec;22(12):858-67. doi: 10.1097/FPC.0b013e32835a450b. Pharmacogenet Genomics. 2012. PMID: 23080225 Free PMC article.

195

Barriers and unmet need for supportive services for HIV patients in care in Los Angeles County, California.

Wohl AR, Carlos JA, Tejero J, Dierst-Davies R, Daar ES, Khanlou H, Cadden J, Towner W, Frye D. Wohl AR, et al. Among authors: daar es. AIDS Patient Care STDS. 2011 Sep;25(9):525-32. doi: 10.1089/apc.2011.0149. Epub 2011 Jul 20. AIDS Patient Care STDS. 2011. PMID: 21774689

196

Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19: A Phase 2 Randomized Clinical Trial.

Chew KW, Moser C, Daar ES, Wohl DA, Li JZ, Coombs R, Ritz J, Giganti M, Javan AC, Li Y, Malvestutto C, Klekotka P, Price K, Nirula A, Fischer W, Bala V, Ribeiro RM, Perelson AS, Fletcher CV, Eron JJ, Currier JS, Hughes MD, Smith DM; ACTIV-2/A5401 Study Team. Chew KW, et al. Among authors: daar es. medRxiv [Preprint]. 2021 Dec 21:2021.12.17.21268009. doi: 10.1101/2021.12.17.21268009. medRxiv. 2021. PMID: 34981077 Free PMC article. Preprint.

197

Shedding of HIV and human herpesviruses in the semen of effectively treated HIV-1-infected men who have sex with men.

Gianella S, Smith DM, Vargas MV, Little SJ, Richman DD, Daar ES, Dube MP, Zhang F, Ginocchio CC, Haubrich RH, Morris SR; CCTG 592 Team. Gianella S, et al. Among authors: daar es. Clin Infect Dis. 2013 Aug;57(3):441-7. doi: 10.1093/cid/cit252. Epub 2013 Apr 17. Clin Infect Dis. 2013. PMID: 23595831 Free PMC article.

198

Incidence of HIV superinfection following primary infection.

Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Daar ES, Richman DD, Little SJ. Smith DM, et al. Among authors: daar es. JAMA. 2004 Sep 8;292(10):1177-8. doi: 10.1001/jama.292.10.1177. JAMA. 2004. PMID: 15353529 No abstract available.

199

Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.

Metsch LR, Feaster DJ, Gooden L, Matheson T, Stitzer M, Das M, Jain MK, Rodriguez AE, Armstrong WS, Lucas GM, Nijhawan AE, Drainoni ML, Herrera P, Vergara-Rodriguez P, Jacobson JM, Mugavero MJ, Sullivan M, Daar ES, McMahon DK, Ferris DC, Lindblad R, VanVeldhuisen P, Oden N, Castellón PC, Tross S, Haynes LF, Douaihy A, Sorensen JL, Metzger DS, Mandler RN, Colfax GN, del Rio C. Metsch LR, et al. Among authors: daar es. JAMA. 2016 Jul 12;316(2):156-70. doi: 10.1001/jama.2016.8914. JAMA. 2016. PMID: 27404184 Free PMC article. Clinical Trial.

200

CD8⁺ Cytotoxic T Lymphocyte Responses and Viral Epitope Escape in Acute HIV-1 Infection.

Kim J, De La Cruz J, Lam K, Ng H, Daar ES, Balamurugan A, Yang OO. Kim J, et al. Among authors: daar es. Viral Immunol. 2018 Sep;31(7):525-536. doi: 10.1089/vim.2018.0040. Epub 2018 Jul 30. Viral Immunol. 2018. PMID: 30059271 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

304 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

304 results

Results by year